Qorvo (QRVO) 10-K 19 May 23 2023 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Apr. 01, 2023	May 12, 2023	Oct. 01, 2022
Document and Entity Information [Abstract]
Document Annual Report	true
City Area Code	336
Local Phone Number	664-1233
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Incorporation, State or Country Code	DE
Document Transition Report	false
Entity Central Index Key	0001604778
Entity File Number	001-36801
Document Period End Date	Apr. 01, 2023
Amendment Flag	false
Document Fiscal Period Focus	FY
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Tax Identification Number	46-5288992
Entity Address, Address Line One	7628 Thorndike Road
Entity Address, Postal Zip Code	27409-9421
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Document Fiscal Year Focus	2023
Document Type	10-K
Entity Registrant Name	Qorvo, Inc.
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Public Float			$ 8,073,738,818
Entity Common Stock, Shares Outstanding		98,736,229
Internal Control over Financial Reporting filed report	true
Current Fiscal Year End Date	--04-01
Auditor Name	Ernst & Young LLP
Auditor Location	Raleigh, North Carolina
Auditor Firm ID	42

Cover

Cover	12 Months Ended
	Apr. 01, 2023
Cover [Abstract]
Documents Incorporated by Reference	The registrant has incorporated by reference into Part III of this report certain portions of its proxy statement for its 2023 annual meeting of stockholders, which is expected to be filed within 120 days after the end of the registrant’s fiscal year ended April 1, 2023.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 01, 2023	Apr. 02, 2022
Current assets:
Cash and cash equivalents	$ 808,757	$ 972,592
Accounts receivable, net of allowance of $369 and $402 as of April 1, 2023 and April 2, 2022, respectively	304,519	568,850
Inventories	796,596	755,748
Prepaid expenses	46,684	49,839
Other Receivables, Net, Current	26,535	32,151
Other current assets	46,703	70,685
Total current assets	2,029,794	2,449,865
Property and equipment, net	1,149,806	1,253,591
Goodwill	2,760,813	2,775,634
Intangible assets, net	537,703	674,786
Long-term investments	20,406	31,086
Other non-current assets	193,381	324,110
Total assets	6,691,903	7,509,072
Current liabilities:
Accounts payable	210,701	327,915
Accrued liabilities	222,463	240,186
Other current liabilities	122,599	107,026
Total current liabilities	555,763	675,127
Long-term debt	2,048,073	2,047,098
Other long-term liabilities	185,273	233,629
Total liabilities	2,789,109	2,955,854
Commitments and contingent liabilities (Note 11)
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 98,649 and 106,303 shares issued and outstanding at April 1, 2023 and April 2, 2022, respectively	3,821,474	4,035,849
Accumulated other comprehensive (loss) income	(3,175)	5,232
Retained Earnings (Accumulated Deficit)	84,495	512,137
Total stockholders’ equity	3,902,794	4,553,218
Total liabilities and stockholders’ equity	$ 6,691,903	$ 7,509,072

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Apr. 01, 2023	Apr. 02, 2022
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 369	$ 402
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common stock, shares authorized	405,000,000	405,000,000
Common stock, shares issued	98,649,000	106,303,000
Common stock, shares outstanding	98,649,000	106,303,000

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 103,152	$ 1,033,353	$ 733,611
Other comprehensive (loss) income, net of tax:
Change in pension liability	1,836	857	(597)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	(10,254)	(25,033)	27,859
Reclassification adjustments, net of tax:
Foreign currency (gain) loss realized upon liquidation of subsidiary	(25)	(359)	16
Amortization of pension actuarial loss	36	118	83
Other comprehensive (loss) income	(8,407)	(24,417)	27,361
Total comprehensive income	$ 94,745	$ 1,008,936	$ 760,972

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Income Statement [Abstract]
Revenue	$ 3,569,399	$ 4,645,714	$ 4,015,307
Cost of goods sold	2,272,457	2,359,546	2,131,741
Gross profit	1,296,942	2,286,168	1,883,566
Operating expenses:
Research and development	649,841	623,636	570,395
Selling, general and administrative	358,790	349,718	367,238
Other operating expense	105,143	86,745	39,306
Total operating expenses	1,113,774	1,060,099	976,939
Operating income	183,168	1,226,069	906,627
Interest expense	(68,463)	(63,326)	(75,198)
Other income (expense), net	9,924	18,341	(24,049)
Income before income taxes	124,629	1,181,084	807,380
Income tax expense	21,477	147,731	73,769
Net income	$ 103,152	$ 1,033,353	$ 733,611
Basic net (loss) income per share	$ (1.01)	$ (9.38)	$ (6.43)
Net income per share:
Diluted	$ (1)	$ (9.26)	$ (6.32)
Weighted-average shares of common stock outstanding:
Basic	102,206	110,196	114,034
Diluted	103,019	111,546	116,016

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Comprehensive Income
Common Stocks, Including Additional Paid in Capital	$ 4,290,377
Accumulated Other Comprehensive Income (Loss), Net of Tax	2,288
Retained Earnings (Accumulated Deficit)	0
Beginning Balance at Mar. 28, 2020	$ 4,292,665
Beginning Balance, Shares at Mar. 28, 2020	114,625
Net income	$ 733,611	$ 0	$ 0	$ 733,611
Other comprehensive income (loss)	27,361	0	27,361	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (29,163)	(29,163)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	1,157
Issuance of common stock in connection with employee stock purchase plan	$ 31,366	31,366	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	417
Cumulative-effect adoption of ASU 2016-13				(38)
Repurchase of common stock, including transaction costs	$ (515,084)	(136,568)	0	(378,516)
Stock-based compensation expense	88,728	88,728	0	0
Cumulative-effect adoption of ASU 2016-02	$ (38)	0	0
Repurchase of common stock, including transaction costs, Shares	(3,642)
Other Retained Earnings Adjustment	$ (21)	0		(21)	$ 0
Ending Balance at Apr. 03, 2021	$ 4,629,425
Ending Balance, Shares at Apr. 03, 2021	112,557
Common Stocks, Including Additional Paid in Capital	$ 4,244,740
Accumulated Other Comprehensive Income (Loss), Net of Tax	29,649
Retained Earnings (Accumulated Deficit)	355,036
Net income	1,033,353	0	0	1,033,353
Other comprehensive income (loss)	(24,417)	0	(24,417)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (49,798)	(49,798)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	779
Issuance of common stock in connection with employee stock purchase plan	$ 33,288	33,288	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	273
Repurchase of common stock, including transaction costs	$ (1,152,287)	(276,035)	0	(876,252)
Stock-based compensation expense	$ 83,654	83,654	0	0
Repurchase of common stock, including transaction costs, Shares	(7,306)
Ending Balance at Apr. 02, 2022	$ 4,553,218
Ending Balance, Shares at Apr. 02, 2022	106,303
Common Stocks, Including Additional Paid in Capital	$ 4,035,849
Accumulated Other Comprehensive Income (Loss), Net of Tax	5,232
Retained Earnings (Accumulated Deficit)	512,137
Net income	103,152	0	0	103,152
Other comprehensive income (loss)	(8,407)	0	(8,407)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (20,847)	(20,847)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	665
Issuance of common stock in connection with employee stock purchase plan	$ 30,169	30,169	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	345
Repurchase of common stock, including transaction costs	$ (862,200)	(331,406)	0	(530,794)
Stock-based compensation expense	$ 107,709	$ 107,709	$ 0	$ 0
Repurchase of common stock, including transaction costs, Shares	(8,664)
Ending Balance at Apr. 01, 2023	$ 3,902,794
Ending Balance, Shares at Apr. 01, 2023	98,649
Common Stocks, Including Additional Paid in Capital	$ 3,821,474
Accumulated Other Comprehensive Income (Loss), Net of Tax	(3,175)
Retained Earnings (Accumulated Deficit)	$ 84,495

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Cash flows from operating activities:
Net income	$ 103,152	$ 1,033,353	$ 733,611
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	206,423	210,949	203,206
Intangible assets amortization	132,425	150,466	252,898
Loss on debt extinguishment	0	744	61,991
Deferred income taxes	(66,145)	31,875	(18,136)
Stock-based compensation expense	105,580	83,507	89,322
Other, net	25,299	14,150	(4,657)
Changes in operating assets and liabilities:
Accounts receivable, net	264,781	(107,896)	(91,275)
Inventories	(81,450)	(236,196)	9,390
Prepaid expenses and other assets	43,240	(176,742)	(18,490)
Accounts payable	(115,495)	33,950	34,201
Accrued liabilities	(17,613)	(11,815)	30,671
Income taxes payable and receivable	(33,240)	(3,139)	34,618
Other liabilities	36,762	(21,963)	(20,778)
Net cash provided by operating activities	843,231	1,049,243	1,301,853
Investing activities:
Purchases of property and equipment	(158,953)	(213,466)	(186,960)
Purchases of businesses, net of cash acquired	(95)	(389,136)	(47,069)
Other investing activities	5,639	6,646	15,371
Net cash used in investing activities	(153,409)	(595,956)	(218,658)
Financing activities:
Repurchase and payment of debt	0	(197,500)	(1,087,994)
Proceeds from borrowings and debt issuances (Note 9)	0	499,070	1,206,750
Repurchase of common stock, including transaction costs	(861,751)	(1,152,287)	(515,084)
Proceeds from the issuance of common stock	32,507	38,303	42,598
Tax withholding paid on behalf of employees for restricted stock units	(23,415)	(53,382)	(38,658)
Other financing activities	(694)	(9,714)	(9,535)
Net cash used in financing activities	(853,353)	(875,510)	(401,923)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(331)	(3,281)	1,425
Net (decrease) increase in cash, cash equivalents and restricted cash	(163,862)	(425,504)	682,697
Cash, cash equivalents and restricted cash at the beginning of the period	972,805	1,398,309	715,612
Cash, cash equivalents and restricted cash at the end of the period	808,943	972,805	1,398,309
Cash and Cash Equivalents, at Carrying Value	808,757	972,592	1,397,880
Restricted Cash	186	213	429
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	808,943	972,805	1,398,309
Interest Paid, Excluding Capitalized Interest, Operating Activities	66,115	59,393	81,232
Income Taxes Paid, Net	105,788	125,322	53,236
Capital Expenditures Incurred but Not yet Paid	33,107	36,069	56,469
Share-based Payment Arrangement, Noncash Expense	105,580	83,507	89,322
Other, net	25,299	14,150	(4,657)
Increase (Decrease) in Accounts Receivable	(264,781)	107,896	91,275
Increase (Decrease) in Inventories	81,450	236,196	(9,390)
Increase (Decrease) in Prepaid Expense and Other Assets	(43,240)	176,742	18,490
Accounts payable	(115,495)	33,950	34,201
Accrued liabilities	(17,613)	(11,815)	30,671
Increase (Decrease) in Income Taxes Payable	(33,240)	(3,139)	34,618
Increase (Decrease) in Other Operating Liabilities	36,762	(21,963)	(20,778)
Net Cash Provided by (Used in) Operating Activities	843,231	1,049,243	1,301,853
Payments to Acquire Property, Plant, and Equipment	158,953	213,466	186,960
Payments to Acquire Businesses, Net of Cash Acquired	95	389,136	47,069
Payments for (Proceeds from) Other Investing Activities	(5,639)	(6,646)	(15,371)
Net Cash Provided by (Used in) Investing Activities	(153,409)	(595,956)	(218,658)
Repayments of Long-term Debt	0	197,500	1,087,994
Proceeds from borrowings and debt issuances (Note 9)	0	499,070	1,206,750
Payments for Repurchase of Common Stock	861,751	1,152,287	515,084
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	32,507	38,303	42,598
Payment, Tax Withholding, Share-based Payment Arrangement	23,415	53,382	38,658
Other financing activities	(694)	(9,714)	(9,535)
Net Cash Provided by (Used in) Financing Activities	(853,353)	(875,510)	(401,923)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(331)	(3,281)	1,425
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(163,862)	(425,504)	682,697
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	808,943	972,805	1,398,309
Cash and Cash Equivalents, at Carrying Value	808,757	972,592	1,397,880
Restricted Cash	186	213	429
Goodwill, Impairment Loss	12,411	48,000	0
Numerator for basic and diluted net (loss) income per share - net (loss) income available to common stockholders	103,152	1,033,353	733,611
Depreciation	206,423	210,949	203,206
Intangible assets amortization	132,425	150,466	252,898
Gain (Loss) on Extinguishment of Debt	0	(744)	(61,991)
Deferred Income Tax Expense (Benefit)	(66,145)	31,875	(18,136)
Maximum number of shares of common stock to be issued under plan	227,101	0	5,281
All other
Adjustments to reconcile net income to net cash provided by operating activities:
Intangible assets amortization	132,126	150,128	252,137
Stock-based compensation expense	105,580	83,507	89,322
Share-based Payment Arrangement, Noncash Expense	105,580	83,507	89,322
Goodwill, Impairment Loss	12,411	48,000	0
Intangible assets amortization	$ 132,126	$ 150,128	$ 252,137

The Company and Its Significant

The Company and Its Significant Accounting Policies	12 Months Ended
	Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies	THE COMPANY AND ITS SIGNIFICANT ACCOUNTING POLICIES Qorvo, Inc. ("the Company") is a global leader in the development and commercialization of technologies and products for wireless, wired and power markets. Qorvo, Inc. was formed as the result of a business combination (the "Business Combination") of RF Micro Devices, Inc. and TriQuint Semiconductor, Inc. ("TriQuint"), which closed on January 1, 2015. The Company’s design expertise and manufacturing capabilities span multiple process technologies. The Company's primary wafer fabrication facilities are in North Carolina, Oregon and Texas, and its primary assembly and test facilities are in China, Costa Rica, Germany and Texas. The Company also sources products and materials through external suppliers. The Company operates design, sales and other manufacturing facilities throughout Asia, Europe and North America. During the second quarter of fiscal 2023, the Company updated its organizational structure to more closely align technologies and applications with customers and end markets. Prior to this organizational change, the Company operated under two segments (Mobile Products ("MP") and Infrastructure and Defense Products ("IDP")), and subsequent to this organizational change, the Company is operating under three segments (High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG")). Refer to Note 17 for additional information regarding the new organizational structure. Principles of Consolidation and Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts (including prior period segment results) have been reclassified to conform to the fiscal 2023 presentation. Accounting Periods The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on April 1, 2023, April 2, 2022 and April 3, 2021. Fiscal years 2023 and 2022 were 52-week years, and fiscal 2021 was a 53-week year. Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the disclosure of contingent liabilities. The Company evaluates its estimates on an ongoing basis, including those related to revenue recognition, product warranty obligations, valuation of inventories, tax related contingencies, valuation of long-lived and intangible assets, other contingencies and litigation, among others. The Company generally bases its estimates on historical experience, expected future conditions and third-party evaluations. The inputs into certain of these estimates and assumptions include the consideration of the impact of the COVID-19 pandemic and other macroeconomic factors. Actual results could differ materially from these estimates, and such differences could affect the operations reported in future periods. Cash and Cash Equivalents Cash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly liquid investments with original maturities of three months or less when purchased. Investments Marketable equity securities consist of common stock in publicly traded companies and are carried at fair value with both the realized and unrealized gains and losses reported in "Other income (expense), net." Fair values of publicly traded equity securities are determined using quoted prices in active markets. The marketable equity securities are classified as short-term based on their highly liquid nature and are recorded in "Other current assets" in the Consolidated Balance Sheets. The Company invests in limited partnerships which are accounted for using the equity method. These equity method investments are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company records its share of the financial results of the limited partnerships in "Other income (expense), net" in the Company's Consolidated Statements of Income. The Company also invests in privately held companies for which the fair value of the investment is not readily determinable. These equity investments without a readily determinable fair value are measured at cost less impairment, adjusted for any changes in observable prices, and are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company assesses these investments for impairment on a quarterly basis and considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include the investee's financial condition and business outlook, market for technology and other relevant events and factors affecting the investee. Investments are impaired when their fair value is less than their carrying value. Fair Value Measurement The Company measures and reports certain financial assets and liabilities on a recurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is described as follows: • Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly, and fair value can be determined through the use of models or other valuation methodologies that do not require significant judgment since the inputs are corroborated by readily observable data. • Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment. The Company also holds assets whose fair value is measured and recorded on a nonrecurring basis. These assets include equity method investments, equity investments without a readily determinable fair value and certain non-financial assets, such as intangible assets and property and equipment. The carrying values of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments. Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). Cost includes labor, materials and manufacturing overhead related to the purchase and production of inventories. In accordance with Accounting Standards Codification ("ASC") 330, "Inventory" ("ASC 330"), abnormal manufacturing costs are charged to "Cost of goods sold" in the period incurred rather than as a portion of inventory cost. The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against demand forecasts on a material or product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of demand forecasts and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve. Product Warranty The Company generally sells products with a limited warranty against defects in materials and workmanship and non-conformance to applicable specifications. The majority of the Company’s product warranty claims are settled through the return of the defective product and the shipment of replacement product. Accruals are estimated based upon both historical experience as well as specifically identified claims. If there is a significant increase in the rate of customer claims compared with the Company's historical experience or if the Company's estimates of probable losses relating to specifically identified warranty exposures require revision, the Company may record a charge against future cost of sales. Product warranty accruals and related expenses were immaterial for the periods presented. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held and used by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as "held for sale" are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Leases The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, the Company assesses whether it has the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset. Right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes renewal options when it is reasonably certain that the option will be exercised and excludes termination options. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. The Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude leases with an initial term of 12 months or less from the balance sheet. Business Acquisitions The Company allocates the fair value of the purchase price to the assets acquired and liabilities assumed based on their estimated fair value. The excess of the purchase price over the fair values of the identifiable assets and liabilities is recorded to goodwill. Goodwill is assigned to the Company's reporting unit that is expected to benefit from the synergies of the business combination. A number of assumptions, estimates and judgments are used in determining the fair value of acquired assets and liabilities, particularly with respect to the intangible assets acquired. The valuation of intangible assets requires the Company to use valuation techniques such as the income approach. The income approach includes management’s estimation of future cash flows (including expected revenue growth rates and profitability), the underlying product or technology life cycles and the discount rates applied to future cash flows. Judgment is also required in estimating the fair values of deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date, as well as inventory, property and equipment, pre-existing liabilities or legal claims, deferred revenue and contingent consideration, each as may be applicable. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the measurement period, any purchase price adjustments are recognized in the Consolidated Statement of Income. Goodwill Impairment Testing In accordance with ASC 350, " Intangibles - Goodwill and Other " ("ASC 350"), goodwill is not amortized, but rather is reviewed for impairment at the reporting unit level on the first day of the Company's fourth quarter of each fiscal year, or when there is evidence that events or changes in circumstances indicate that the carrying amount of the goodwill may not be recovered. Under ASC 350, the Company has the option to first assess qualitatively whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. In performing qualitative assessments, the Company considers (i) its overall historical and projected future operating results, (ii) if there was a significant decline in its stock price for a sustained period, (iii) if there was a significant change in its market capitalization relative to its net book value, and (iv) if there was a prolonged or more significant slowdown in the worldwide economy of the semiconductor industry, as well as other relevant events and factors affecting the reporting unit. If qualitative assessments conclude that it is more likely than not that the fair value of any reporting unit is less than its carrying value, quantitative assessments are performed on the applicable reporting units. The quantitative assessments consider both the income and market approaches to estimate the fair value of a reporting unit. The income approach is based on the discounted cash flow method that uses estimates of the reporting unit's forecasted future financial performance including revenue, operating expenses, taxes and capital expenditures. These estimates are developed as part of the Company's long-term planning process based on assumed market segment growth rates and its assumed market segment share, estimated costs based on historical data and various internal estimates. Projected cash flows are then discounted to a present value employing a discount rate that properly accounts for the estimated market weighted-average cost of capital, as well as any risk unique to the cash flows. The market approach is based on financial multiples (i.e., multiples of revenue or earnings before income taxes, depreciation and amortization) of comparable companies. Refer to Note 6 for additional information regarding goodwill and intangible asset impairment testing. Identified Intangible Assets The Company amortizes definite-lived intangible assets (including developed technology, customer relationships, technology licenses, backlog and trade names) over their estimated useful lives. IPRD assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of the acquisition and are initially not subject to amortization. Upon completion of development, IPRD assets are transferred to developed technology and are amortized over their useful lives. The asset balances relating to abandoned projects are impaired and expensed to R&D. The Company evaluates definite-lived intangible assets for impairment in accordance with ASC 360-10-35, " Impairment or Disposal of Long-Lived Assets " to determine whether facts and circumstances (including external factors such as industry and economic trends and internal factors such as changes in the Company’s business strategy and forecasts) indicate that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amounts over the fair value of those assets and occur in the period in which the impairment determination was made. Revenue Recognition The Company generates revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, or at completion of a consignment process. Revenue is recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. A majority of the Company's revenue is recognized at a point in time, either on shipment or delivery of the product, depending on individual customer terms and conditions. Revenue from sales to the Company’s distributors is recognized upon shipment of the product to the distributors (sell-in). Revenue is recognized from the Company’s consignment programs at a point in time when the products are pulled from consignment inventory by the customer. Revenue recognized for products and services over time is less than 4% of overall revenue. The Company applies a five-step approach as defined in ASC 606, " Revenue from Contracts with Customers, " in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when the corresponding performance obligation is satisfied. Sales agreements are in place with certain customers and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require minimum purchase commitments. In the absence of a sales agreement, the Company’s standard terms and conditions apply. The Company considers a customer's purchase order, which is governed by a sales agreement or the Company’s standard terms and conditions, to be the contract with the customer. The Company’s pricing terms are negotiated independently, on a stand-alone basis. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Variable consideration in the form of rebate programs is offered to certain customers, including distributors, and represents less than 7% of net revenue. The Company determines variable consideration by estimating the most likely amount of consideration it expects to receive from the customer. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company may authorize sales returns under certain circumstances, which include courtesy returns and like-kind exchanges. The Company reduces revenue and records reserves for product returns and allowances, rebate programs and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company’s accounts receivable balance is from contracts with customers and represents the Company’s unconditional right to receive consideration from its customers. Payments are due upon completion of the performance obligation and subsequent invoicing. Substantially all payments are collected within the Company’s standard terms, which do not include any financing components. There have been no material impairment losses on accounts receivable for fiscal years 2023, 2022 or 2021. Contract assets and contract liabilities recorded on the Consolidated Balance Sheets were immaterial as of April 1, 2023 and April 2, 2022. The Company invoices customers upon shipment and recognizes revenue in accordance with delivery terms. As of April 1, 2023, the Company had $167.8 million in remaining unsatisfied performance obligations with an original duration greater than one year, of which the majority is expected to be recognized as income over the next 12 months. The Company includes shipping charges billed to customers in "Revenue" and includes the related shipping costs in "Cost of goods sold" in the Consolidated Statements of Income. Taxes assessed by government authorities on revenue-producing transactions, including tariffs, value-added and excise taxes, are excluded from revenue in the Consolidated Statements of Income. The Company incurs commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded in the "Selling, general and administrative" expense line item in the Consolidated Statements of Income) are expensed when incurred because such commissions are not owed until the performance obligation is satisfied, which coincides with the end of the contract term, and therefore, no remaining period exists over which to amortize the commissions. Research and Development The Company charges all R&D costs to expense as incurred. Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more-likely-than-not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. It is the Company’s current intent and policy to repatriate certain previously taxed earnings of foreign subsidiaries from outside the U.S. Accordingly, the Company recognizes a deferred tax liability for income taxes on certain unremitted foreign earnings of foreign subsidiaries. For earnings which remain permanently reinvested, it is not practical to estimate the additional tax that would be incurred, if any, if the permanently reinvested earnings were repatriated. Stock-Based Compensation Under ASC 718, " Compensation – Stock Compensation, " stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of April 1, 2023, total remaining unearned compensation cost related to unvested restricted stock units was $137.6 million, which will be amortized over the weighted-average remaining service period of approximately 1.3 years. Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with ASC 830, " Foreign Currency Matters. " The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenue and expenses are translated using the weighted-average exchange rates throughout the year. Translation adjustments are shown separately as a component of "Accumulated other comprehensive (loss) income" within "Stockholders’ equity" in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in "Other income (expense), net" in the Consolidated Statements of Income. Supplemental Financial Information The "Accrued liabilities" balance as of April 1, 2023 and April 2, 2022, includes accrued compensation and benefits of $92.9 million and $113.6 million, respectively, and accrued rebates of $42.8 million and $33.1 million, respectively. The "Other current liabilities" balance as of April 1, 2023 includes income taxes payable of $63.6 million and contingent consideration related to the acquisition of United Silicon Carbide, Inc. ("United SiC") of $31.3 million. The "Other current liabilities" balances as of April 2, 2022 includes income taxes payable of $87.8 million. Recent Accounting Pronouncements and Other Developments In November 2021, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2021-10, "Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance " to increase transparency about certain government assistance or grants received by a business entity. This new guidance requires the disclosure of (1) the types of assistance, (2) an entity's accounting for the assistance, and (3) the effect of the assistance on an entity's financial statements. The Company adopted ASU 2021-10 on April 3, 2022. From time to time, the Company receives cash grants and tax abatements from U.S. federal and state governments and non-U.S. governments which, in most cases, attach conditions for a specific duration period and generally relate to hiring employees, the construction or acquisition of assets or to developing specific technologies. If conditions are not satisfied, or the duration period for the agreement is infringed, the incentives are subject to reduction, termination, or recapture. The Company's accounting policy is to recognize a benefit to the income statement over the duration of the program when the conditions, including the required spending attached to the incentive are achieved and the Company is expected to complete any further requirements. A grant that compensates for operational expenses is recognized as a reduction from the nature of the expense the grant is designated to offset. A grant related to property, plant and equipment investments is recognized as a reduction to the cost-basis of the underlying assets with an ongoing reduction to depreciation expense based on the useful lives of the related assets. During fiscal 2023, the Company received a nominal amount related to these programs. In August 2022, the Creating Helpful Incentives to Produce Semiconductors and Science Act (the "CHIPS Act") was signed into law. The CHIPS Act provides for a 25% refundable tax credit on certain investments in domestic semiconductor manufacturing. The credit is provided for qualifying property, which is placed in service after December 31, 2022. The CHIPS Act also provides for certain other financial incentives to further investments in domestic semiconductor manufacturing. The Company is evaluating the provisions of the new law and its potential impact to the Company. In August 2022, the Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new book minimum tax of 15% on consolidated adjusted GAAP pre-tax earnings for corporations with average income in excess of $1 billion and is effective for tax years beginning after December 31, 2022. In addition, the IRA also introduced a nondeductible 1% excise tax on a publicly traded corporation for the net value of certain stock

Concentrations of Credit Risk

Concentrations of Credit Risk	12 Months Ended
	Apr. 01, 2023
Risks and Uncertainties [Abstract]
CONCENTRATIONS OF CREDIT RISK	CONCENTRATIONS OF CREDIT RISK The Company’s principal financial instrument subject to potential concentration of credit risk is accounts receivable, which is unsecured. The Company provides an allowance for doubtful accounts equal to estimated losses expected to be incurred in the collection of accounts receivable. The Company's trade receivables are evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics, adjusting for broad-based economic indicators as well as customer specific factors. The Company has adopted credit policies and standards intended to accommodate industry growth and inherent risk and it believes that credit risks are moderated by the financial stability of its major customers, conservative payment terms and the Company’s strict credit policies. The Company provides products to its largest end customer, Apple Inc., through sales to multiple contract manufacturers, which in the aggregate accounted for approximately 37%, 33% and 30% of total revenue in fiscal years 2023, 2022 and 2021, respectively. Samsung Electronics Co., Ltd., accounted for approximately 12%, 11% and 7% of total revenue in fiscal years 2023, 2022 and 2021, respectively. These customers primarily purchase radio frequency ("RF") solutions for a variety of mobile devices from the Company's ACG segment. The Company's three largest accounts receivable balances comprised approximately 54% and 57% of aggregate gross accounts receivable as of April 1, 2023 and April 2, 2022, respectively.

Inventories

Inventories	12 Months Ended
	Apr. 01, 2023
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES The components of inventories, net of reserves, are as follows (in thousands): April 1, 2023 April 2, 2022 Raw materials $ 264,367 $ 236,095 Work in process 345,545 357,332 Finished goods 186,684 162,321 Total inventories $ 796,596 $ 755,748

Property and Equipment

Property and Equipment	12 Months Ended
	Apr. 01, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment	PROPERTY AND EQUIPMENT The components of property and equipment are as follows (in thousands): April 1, 2023 April 2, 2022 Land $ 25,842 $ 25,842 Building and leasehold improvements 463,888 432,305 Machinery and equipment 2,430,307 2,401,735 Construction in progress 130,086 128,317 Total property and equipment, gross 3,050,123 2,988,199 Less accumulated depreciation (1,900,317) (1,734,608) Total property and equipment, net $ 1,149,806 $ 1,253,591

Business Acquisitions

Business Acquisitions	12 Months Ended
	Apr. 01, 2023
BUSINESS ACQUISITION DISCLOSURE [Abstract]
BUSINESS ACQUISITIONS	BUSINESS ACQUISITIONSDuring fiscal 2022, the Company completed the acquisitions of United SiC and NextInput, Inc. ("NextInput"). During fiscal 2021, the Company completed the acquisition of 7Hugs Labs S.A.S. ("7Hugs"). The goodwill resulting from these acquisitions is attributed to synergies and other benefits that are generated from these transactions. The operating results of these companies, which were not material either individually or in the aggregate, have been included in the Company's consolidated financial statements as of the acquisition dates. As a result, pro forma results of operations for these acquisitions have not been presented. United Silicon Carbide, Inc. On October 19, 2021, the Company acquired all the outstanding equity interests of United SiC, a leading manufacturer of silicon carbide ("SiC") power semiconductors, for a total purchase price of $236.7 million. The acquisition expanded the Company's offerings to include SiC power products for a range of applications such as electric vehicles, battery charging, IT infrastructure, renewables and circuit protection. The purchase price comprised cash consideration of $227.2 million and contingent consideration of up to $31.3 million which is to be paid to the sellers during the first quarter of fiscal 2024 (in accordance with the terms of the acquisition agreement) due to the achievement of certain revenue and gross margin targets over the period beginning on the acquisition date through December 31, 2022. The estimated fair value of the contingent consideration liability was $9.5 million as of the acquisition date. At April 2, 2022, the contingent consideration liability was remeasured to a fair value of $17.6 million and is included in "Other long-term liabilities" in the Consolidated Balance Sheet. The maximum contingent consideration of $31.3 million has been earned and is included in "Other current liabilities" in the Consolidated Balance Sheet as of April 1, 2023, with the increase in fair value recognized in "Other operating expense" in the Consolidated Statement of Income. Refer to Note 7 for further information related to the fair value measurement. During fiscal years 2023 and 2022, the Company recorded acquisition and integration related costs associated with the acquisition of United SiC totaling $14.6 million and $12.2 million, respectively, in "Other operating expense" in the Consolidated Statements of Income. During fiscal 2022, the Company also recorded $3.6 million of acquisition and integration related costs in "Cost of goods sold" in the Consolidated Statement of Income. NextInput, Inc. On April 5, 2021, the Company acquired all the outstanding equity interests of NextInput, a leader in microelectromechanical system ("MEMS")-based sensing solutions, for a total cash purchase price of $173.3 million. The acquisition expanded the Company's offerings of MEMS-based products for mobile applications, providing sensing solutions for a broad range of applications in other markets. During fiscal years 2023, 2022 and 2021, the Company recorded acquisition and integration related costs associated with the acquisition of NextInput totaling $2.1 million, $2.7 million and $1.8 million, respectively, in "Other operating expense" in the Consolidated Statements of Income. In connection with the Company's fiscal 2022 annual qualitative goodwill impairment assessment, it was determined that the market adoption of the acquired NextInput technology into mobile handsets was expected to be delayed compared to the previous assumptions. As a result, the Company completed a quantitative assessment of its reporting unit, which resulted in a goodwill impairment charge of $48.0 million. 7Hugs Labs S.A.S. In fiscal 2021, the Company acquired all the outstanding equity interests of 7Hugs, a private developer of ultra - wideband ("UWB") software and solutions, for a total cash purchase price of $48.7 million. During fiscal years 2023, 2022 and 2021, the Company recorded acquisition and integration related costs associated with the acquisition of 7Hugs totaling $0.1 million, $0.2 million and $2.4 million, respectively, in "Other operating expense" in the Consolidated Statements of Income.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Apr. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS The changes in the carrying amount of goodwill for fiscal 2023 are as follows (in thousands): HPA CSG ACG Total Balance as of April 2, 2022 (1) $ 501,899 $ 539,875 $ 1,733,860 $ 2,775,634 NextInput measurement period adjustments — 572 — 572 United SiC measurement period adjustments (297) — — (297) Goodwill impairment — (12,411) — (12,411) Effect of changes in foreign currency exchange rates — (2,685) — (2,685) Balance as of April 1, 2023 (1) $ 501,602 $ 525,351 $ 1,733,860 $ 2,760,813 (1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $682.0 million and $669.6 million as of April 1, 2023 and April 2, 2022, respectively, which were recognized in fiscal years 2009, 2013, 2014 2022 and 2023. During the second quarter of fiscal 2023, the Company updated its organizational structure to more closely align technologies and applications with customers and end markets. Prior to the Reorganization ("Pre-Reorganization"), the Company operated under two segments with a total of five reporting units and subsequent to the Reorganization ("Post-Reorganization"), it is operating under three segments with a total of eight reporting units. In accordance with ASC 350, quantitative impairment assessments on each reporting unit were performed immediately before and after the change in organizational structure. Based on the Pre-Reorganization quantitative assessment performed on July 2, 2022, management concluded there was no goodwill impairment. Based on the Post-Reorganization quantitative analysis performed on July 3, 2022 (the "Quantitative Analysis"), it was determined the fair value of five of the eight reporting units significantly exceeded their carrying values. Therefore, for the annual goodwill impairment assessment that was performed as of January 1, 2023, the Company opted to perform a qualitative impairment assessment for the goodwill related to these five reporting units. The Company concluded based on the relevant facts and circumstances, including the Quantitative Analysis performed, it was more likely than not that the fair value of each of these reporting units exceeded their related carrying value and no further impairment testing was required. In addition, based on the Quantitative Analysis, it was determined the fair value of three of the eight reporting units did not significantly exceed their carrying values. Therefore, the Company performed additional quantitative analyses on two of these reporting units and concluded that based on the relevant facts and circumstances, it was more likely than not that the fair value of each of these reporting units exceeded their related carrying value and no further impairment testing was required. As part of ongoing efforts to focus on growth drivers and key markets and to streamline operations, in the fourth quarter of fiscal 2023, the Company began to seek strategic alternatives for the third reporting unit (the Company's non-core biotechnology business). Given the future funding requirements necessary to further develop its diagnostic testing solutions and achieve the desired results, the Company decided not to invest further in this business. Therefore, the Company determined that there was a more-likely-than-not expectation of selling or disposing of all, or a portion, of this reporting unit, and impairment testing was triggered. An evaluation of the asset group within this reporting unit was performed which resulted in an impairment of equipment and inventory (refer to Note 12 for additional information). Based on these facts and circumstances, the Company determined the carrying value exceeded the fair value of this reporting unit which resulted in a goodwill impairment charge of $12.4 million (representing the entire goodwill assigned to this reporting unit). In fiscal 2022, the Company recorded a goodwill impairment charge of $48.0 million related to its NextInput business. This charge in recorded in "Other operating expense" in the fiscal 2022 Consolidated Statement of Income. The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): April 1, 2023 April 2, 2022 Gross Accumulated Gross Accumulated Developed technology $ 872,106 $ 382,448 $ 1,026,690 $ 420,255 Customer relationships 104,616 67,485 104,778 47,208 Technology licenses 1,664 513 2,641 2,169 Trade names 910 789 1,933 1,358 IPRD 9,642 N/A 9,734 N/A Total (1) $ 988,938 $ 451,235 $ 1,145,776 $ 470,990 (1) Amounts include the impact of foreign currency translation. At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets. No definite-lived intangible asset impairment charges were recorded for fiscal years 2023 or 2022. Total intangible assets amortization expense was $132.4 million, $150.5 million and $252.9 million in fiscal years 2023, 2022 and 2021, respectively. The following table provides the Company's estimated amortization expense for intangible assets for the periods indicated (in thousands): Fiscal Year Estimated 2024 $ 121,000 2025 105,000 2026 95,000 2027 82,000 2028 54,000

Investments and Fair Value Meas

Investments and Fair Value Measurements	12 Months Ended
	Apr. 01, 2023
Investments and Fair Value Measurements [Abstract]
INVESTMENTS AND FAIR VALUE MEASUREMENTS	INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS Equity Method Investments The Company invests in limited partnerships and accounts for these investments using the equity method. The carrying amounts of these investments as of April 1, 2023 and April 2, 2022 were $20.4 million and $27.1 million, respectively, and are classified as "Long-term investments" in the Consolidated Balance Sheets. During fiscal years 2023, 2022 and 2021, the Company recorded a loss of $4.2 million and income of $12.0 million and $21.5 million, respectively, based on its share of the limited partnerships' earnings in "Other income (expense), net" in the Consolidated Statements of Income. The Company received cash distributions totaling $2.5 million, $14.8 million and $5.9 million during fiscal years 2023, 2022 and 2021, respectively. The cash distributions were recognized as reductions to the carrying value of the investments and included in the cash flows from investing activities in the Consolidated Statements of Cash Flows. Fair Value of Financial Instruments The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands): Total Quoted Prices In Significant Other Significant April 1, 2023 Marketable equity securities $ 1,094 $ 1,094 $ — $ — Invested funds in deferred compensation plan (1) 40,653 40,653 — — Contingent earn-out liability (2) (31,250) — — (31,250) April 2, 2022 Marketable equity securities $ 2,906 $ 2,906 $ — $ — Invested funds in deferred compensation plan (1) 39,356 39,356 — — Contingent earn-out liability (2) (17,600) — — (17,600) (1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share as determined by quoted active market prices of the underlying investments. Refer to Note 10 for further information on the Company's non-qualified deferred compensation plan. (2) The fair value of the contingent consideration liability which related to the acquisition of United SiC (refer to Note 5 ) was equal to the maximum amount payable at April 1, 2023 and was estimated using an option pricing model at April 2, 2022.

Leases

Leases	12 Months Ended
	Apr. 01, 2023
Leases [Abstract]
Lessee, Operating Leases	LEASES The Company leases certain of its corporate, manufacturing and other facilities from multiple third-party real estate developers. The Company also leases various machinery and office equipment. These operating leases expire at various dates through 2036, and some of these leases have renewal options, with the longest ranging up to two, ten-year periods. Operating leases are classified as follows (in thousands): April 1, 2023 April 2, 2022 Other non-current assets $ 83,490 $ 73,683 Other current liabilities 19,357 17,393 Other long-term liabilities 69,156 61,511 Details of operating leases are as follows (in thousands): Fiscal Year 2023 2022 2021 Operating lease expense $ 20,162 $ 19,178 $ 17,382 Short-term lease expense 7,798 7,726 7,062 Variable lease expense 5,386 4,886 3,972 Cash paid for amounts included in the measurement of operating lease liabilities 21,480 20,536 18,697 Right-of-use assets obtained in exchange for new operating lease liabilities 28,940 29,210 12,899 The weighted-average remaining lease term and weighted-average discount rate for operating leases are as follows: April 1, 2023 April 2, 2022 Weighted-average remaining lease term (years) 6.5 6.9 Weighted-average discount rate 3.98 % 2.99 % The aggregate future lease payments for operating leases as of April 1, 2023 are as follows (in thousands): Fiscal Year Lease Payments 2024 $ 22,037 2025 17,516 2026 15,270 2027 12,350 2028 11,270 Thereafter 21,150 Total future lease payments 99,593 Less imputed interest (11,080) Present value of lease liabilities $ 88,513

Debt

Debt	12 Months Ended
	Apr. 01, 2023
Debt Disclosure [Abstract]
DEBT	LONG-TERM DEBT Long-term debt is as follows (in thousands): April 1, 2023 April 2, 2022 1.750% senior notes due 2024 $ 500,000 $ 500,000 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Finance leases and other 1,666 2,581 Unamortized premium, discount and issuance costs, net (3,283) (4,692) Less current portion of long-term debt (310) (791) Total long-term debt $ 2,048,073 $ 2,047,098 Credit Agreement On September 29, 2020, the Company and certain of its U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million, and included a senior term loan, that was fully repaid in fiscal 2022. The Revolving Facility is available to finance working capital, capital expenditures and other general corporate purposes. Pursuant to the Credit Agreement, the Company may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and subject to, among other things, securing additional funding commitments from the existing or new lenders. On April 6, 2022, the Company and the administrative agent entered into an amendment to the Credit Agreement (the "LIBOR Transition Amendment") to replace the London Interbank Offered Rate as a reference rate available for use in the computation of interest under the Credit Agreement. As a result of the LIBOR Transition Amendment, at the Company’s option, loans under the Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the administrative agent, and (c) the Term SOFR plus 1.0% (the "Base Rate"). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Term SOFR is the rate per annum equal to the forward-looking Secured Overnight Financing Rate term rate for interest periods of one, three or six months (as selected by the Company) plus an adjustment (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.250% per annum, and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum. Undrawn amounts under the Revolving Facility are subject to a commitment fee ranging from 0.150% to 0.200%. During fiscal years 2023 and 2022, there were no borrowings under the Revolving Facility. The Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and to avoid an event of default. As of April 1, 2023, the Company was in compliance with these covenants. Senior Notes due 2024 On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants. The 2024 Notes have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities laws, and, unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. In connection with the offering of the 2024 Notes, the Company entered into a Registration Rights Agreement, dated as of December 14, 2021 (the "Registration Rights Agreement"), by and among the Company and the Guarantors, on the one hand, and BofA Securities, Inc., as representative of the initial purchasers of the 2024 Notes, on the other hand. Under the Registration Rights Agreement, the Company and the Guarantors have agreed to use their commercially reasonable efforts to (i) file with the SEC a registration statement (the "Exchange Offer Registration Statement") relating to the registered exchange offer (the "Exchange Offer") to exchange the 2024 Notes for a new series of the Company’s exchange notes having terms substantially identical in all material respects to, and in the same aggregate principal amount as, the 2024 Notes; (ii) cause the Exchange Offer Registration Statement to be declared effective by the SEC; and (iii) cause the Exchange Offer to be consummated no later than the 720th day after December 14, 2021 (or if such 720th day is not a business day, the next succeeding business day). Under certain circumstances, the Company and the Guarantors have agreed to use their commercially reasonable efforts to (i) file a shelf registration statement relating to the resale of the 2024 Notes as promptly as practicable, and (ii) cause the shelf registration statement to be declared effective by the SEC as promptly as practicable. If the Company fails to meet any of these targets, the annual interest rate on the 2024 Notes will increase by 0.25% during the 90-day period following the default and will increase by an additional 0.25% for each subsequent 90-day period during which the default continues, up to a maximum additional interest rate of 1.00% per year. If the Company cures the default, the interest rate on the 2024 Notes will revert to the original level. Interest is payable on the 2024 Notes on June 15 and December 15 of each year. Interest paid on the 2024 Notes during fiscal 2023 was $8.8 million. Senior Notes due 2029 On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019 and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and collectively with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019 and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. At any time prior to October 15, 2024, the Company may redeem all or part of the 2029 Notes, at a redemption price equal to 100% of their principal amount, plus a "make whole" premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to October 15, 2024, the Company may redeem up to 35% of the original aggregate principal amount of the 2029 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 104.375%, plus accrued and unpaid interest. Furthermore, at any time on or after October 15, 2024, the Company may redeem the 2029 Notes, in whole or in part, at the redemption prices specified in the 2019 Indenture, plus accrued and unpaid interest. Interest is payable on the 2029 Notes on April 15 and October 15 of each year. Interest paid on the 2029 Notes during fiscal years 2023, 2022 and 2021 was $37.2 million, $37.2 million and $31.6 million, respectively. Senior Notes due 2031 On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. At any time prior to April 1, 2026, the Company may redeem all or part of the 2031 Notes, at a redemption price equal to 100% of their principal amount, plus a "make whole" premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to April 1, 2026, the Company may redeem up to 40% of the original aggregate principal amount of the 2031 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 103.375%, plus accrued and unpaid interest. Furthermore, at any time on or after April 1, 2026, the Company may redeem the 2031 Notes, in whole or in part, at the redemption prices specified in the 2020 Indenture, plus accrued and unpaid interest. The 2031 Notes have not been and will not be registered under the Securities Act, or any state securities laws, and may not be offered or sold in the United States absent an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. Interest is payable on the 2031 Notes on April 1 and October 1 of each year. Interest paid on the 2031 Notes during fiscal years 2023, 2022 and 2021 was $23.6 million, $23.6 million and $11.9 million, respectively. Senior Notes due 2025 On December 1, 2020, the Company redeemed the remaining $23.4 million principal amount of its 7.00% senior notes due December 1, 2025 (the "2025 Notes") using cash on hand, at a redemption price equal to 103.50% of the principal amount, plus accrued and unpaid interest. Interest paid on the 2025 Notes during fiscal 2021 was $1.6 million. Senior Notes due 2026 On October 16, 2020, the Company redeemed the $900.0 million aggregate principal amount of its 5.50% senior notes due July 15, 2026 (the "2026 Notes") at a redemption price equal to 106.363% of the $900.0 million principal amount, plus accrued and unpaid interest. The 2026 Notes were redeemed using proceeds from the issuance of the 2031 Notes combined with cash on hand plus borrowings under a term loan. In connection with the redemption, the Company recognized a loss on debt extinguishment of $61.0 million as "Other (expense) income, net" in the fiscal 2021 Consolidated Statement of Income. The loss on debt extinguishment consisted of a $57.3 million redemption premium and a $3.7 million net write-off of unamortized debt issuance costs and bond premium. The primary purpose of the redemption was to reduce future interest expense. Interest paid on the 2026 Notes during fiscal 2021 was $37.3 million. Fair Value of Long-Term Debt The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 1, 2023 was $464.2 million, $785.9 million and $565.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 2, 2022 was $476.9 million, $852.6 million and $638.6 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter and the fair values were estimated based upon the value of the last trade at the end of the period. Interest Expense During fiscal 2023, the Company recognized $72.3 million of interest expense primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, which was partially offset by $3.9 million of interest capitalized to property and equipment. During fiscal 2022, the Company recognized $67.0 million of interest expense primarily related to the 2029 Notes and the 2031 Notes, which was partially offset by $3.7 million of interest capitalized to property and equipment. During fiscal 2021, the Company recognized $79.3 million of interest expense primarily related to the 2026 Notes (redeemed on October 16, 2020), the 2029 Notes and the 2031 Notes, which was partially offset by $4.1 million of interest capitalized to property and equipment.

Retirement Benefit Plans

Retirement Benefit Plans	12 Months Ended
	Apr. 01, 2023
Retirement Benefits [Abstract]
RETIREMENT BENEFIT PLANS	RETIREMENT BENEFIT PLANS Defined Contribution Plans The Company offers tax-beneficial retirement contribution plans to eligible employees in the U.S. and certain other countries. Eligible employees in certain countries outside of the U.S. are eligible to participate in stakeholder, group or national pension plans with differing eligibility and contributory requirements based on local and national regulations. U.S. employees are eligible to participate in the Company's fully qualified 401(k) plan 30 days after their date of hire. An employee may contribute and invest pretax and/or Roth dollars into the 401(k) plan up to the maximum legal limits (as defined by Federal regulations). Employer contributions to the 401(k) plan are made at the discretion of the Company’s Board of Directors. Employees are immediately vested in their own contributions as well as employer matching contributions. In total, the Company contributed $18.8 million, $17.6 million and $15.6 million to its domestic and foreign defined contribution plans during fiscal years 2023, 2022 and 2021, respectively. Defined Benefit Pension Plans The Company maintains two qualified defined benefit pension plans for its subsidiaries located in Germany. One of the plans is funded through a self-paid reinsurance program with assets valued at $3.8 million as of April 1, 2023 and April 2, 2022 (included in "Other non-current assets" in the Consolidated Balance Sheets). The pension benefit obligations of both plans were $9.4 million and $12.1 million as of April 1, 2023 and April 2, 2022, respectively, which is included in "Accrued liabilities" and "Other long-term liabilities" in the Consolidated Balance Sheets. The benefit obligations for the plans are calculated annually by an independent actuary and require the use of significant judgment including assumptions based on local economic conditions. The net periodic benefit cost was approximately $0.5 million for fiscal 2023 and $0.6 million for fiscal years 2022 and 2021. Non-Qualified Deferred Compensation Plan Certain employees and members of the Board of Directors are eligible to participate in the Company's Non-Qualified Deferred Compensation Plan ("NQDC Plan"). The NQDC Plan provides eligible participants the opportunity to defer and invest a specified percentage of their cash compensation. The NQDC Plan is a non-qualified plan that is maintained in a rabbi trust, which restricts the Company's use and access to the assets held but is subject to the claims of the Company's creditors in the event that the Company becomes insolvent. The amount of compensation to be deferred by each participant is based on their own elections and is adjusted for any investment changes that the participant directs. This plan does not provide for employer contributions. The deferred compensation obligation and the fair value of the investments held in the rabbi trust were $40.7 million and $39.4 million as of April 1, 2023 and April 2, 2022, respectively. The current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $1.6 million and $1.5 million as of April 1, 2023 and April 2, 2022, respectively, and are included in "Other current assets" and "Accrued liabilities" in the Consolidated Balance Sheets. The non-current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $39.1 million and $37.9 million as of April 1, 2023 and April 2, 2022, respectively, and are included in "Other non-current assets" and "Other long-term liabilities" in the Consolidated Balance Sheets.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	12 Months Ended
	Apr. 01, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS AND CONTINGENT LIABILITIES Purchase Obligations As of April 1, 2023, the Company's purchase obligations (including capital commitments and purchase commitments under a long-term capacity reservation agreement) totaled approximately $1,283.7 million, of which approximately $657.1 million is expected to be paid during fiscal 2024. In subsequent years, the Company expects to pay approximately $356.5 million, $227.6 million and $42.5 million related to these purchase obligations during fiscal years 2025, 2026 and 2027, respectively. Noncancelable purchase obligations represent payments due related to the purchase of materials, manufacturing services and property and equipment, a majority of which are not recorded as liabilities in the Consolidated Balance Sheet because the Company has not received the related goods or services as of April 1, 2023. Amidst ongoing industry-wide supply constraints, the Company entered into a long-term capacity reservation agreement with a foundry supplier during the second quarter of fiscal 2022. Under this agreement, the Company was required to purchase, and the foundry supplier was required to supply, a certain number of wafers (at predetermined sales prices) for calendar years 2022 through 2025. In connection with this agreement, the Company paid a refundable deposit (which was recorded in "Other non-current assets" in the Consolidated Balance Sheets), and if the purchase commitments per the agreement were not met, under certain circumstances the supplier could deduct the amount of the purchase shortfall from the prepaid refundable deposit at the end of each calendar year. During fiscal 2023, the Company experienced unexpectedly weakened demand for 5G handsets in China and EMEA due to unprecedented disruption resulting, in part, from measures taken in China to control the COVID-19 pandemic and the war in Ukraine. As a result, the Company did not meet the minimum purchase commitments under this long-term capacity reservation agreement. In the first quarter of fiscal 2023, the purchase shortfall resulted in an impairment to the prepaid refundable deposit of approximately $13.0 million, and additional reserves of approximately $11.0 million for inventory in excess of demand forecasts were recorded. Additionally, the Company assessed the future minimum purchase commitments over the remaining term of the agreement and recorded an estimated shortfall of $86.0 million, of which $8.0 million was recorded in "Other current liabilities" and $78.0 million was recorded in "Other long-term liabilities" in accordance with ASC 330. These transactions resulted in a total increase to cost of goods sold of $110.0 million in the first quarter of fiscal 2023. In October 2022, the Company renegotiated the terms of the agreement with the foundry supplier, which included extending the duration of the agreement through calendar year 2026. As a result of the amended agreement, in the second quarter of fiscal 2023, the Company recorded an impairment to the prepaid refundable deposit of approximately $38.0 million and additional reserves of approximately $5.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $43.0 million. In the third quarter of fiscal 2023, the Company recorded an impairment to the prepaid refundable deposit of approximately $8.0 million and additional reserves of approximately $4.0 million for inventory in excess of demand forecasts, which reduced the estimated shortfall liability that was previously recorded by $12.0 million. There was no impact to the statements of operations in the second or third quarters of fiscal 2023. In the fourth quarter of fiscal 2023, the Company elected to apply the remaining prepaid refundable deposit against portions of its monthly purchase commitments for the term of the amended agreement in lieu of ordering certain additional silicon wafers. This election was made in order to better align component inventory with the timing of the forecasted finished goods demand and resulted in an impairment to the prepaid refundable deposit of $71.0 million, increasing cost of goods sold by $71.0 million in the fourth quarter of fiscal 2023. The Company considers customer forecasts, legal obligations, macroeconomic and geopolitical factors as well as market and industry trends, when assessing future minimum purchase commitments. These factors include significant management judgment and estimates and, to the extent that these assumptions are incorrect or there are further declines in customer forecasts, additional charges may be recorded in future periods. Lease Commitments Refer to Note 8 for disclosures related to lease commitments. Legal Matters The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

Restructuring

Restructuring	12 Months Ended
	Apr. 01, 2023
Restructuring and Related Activities [Abstract]
RESTRUCTURING	RESTRUCTURINGThe Company initiated actions to improve efficiencies in its operations and further align the organization with its strategic objectives, which resulted in approximately $32.5 million of restructuring charges recorded in the nine months ended December 31, 2022 (primarily related to the impairment of equipment and a contract cancellation fee). As part of ongoing efforts to focus on growth drivers and key markets and to streamline operations, in the fourth quarter of fiscal 2023, the Company began to seek strategic alternatives related to its non-core biotechnology business. Given the future funding requirements necessary to further develop its diagnostic testing solutions and achieve the desired results, the Company decided not to invest further in this business. Therefore, the Company determined that there was a more-likely-than-not expectation of selling or disposing of all, or a portion, of this reporting unit, and impairment testing was triggered. An evaluation of the asset group within this reporting unit was performed which resulted in an impairment of equipment and inventory of approximately $74.8 million and other charges of approximately $6.8 million. Based on these facts and circumstances, the Company determined that the carrying value exceeded the fair value of this reporting unit which resulted in a goodwill impairment charge of approximately $12.4 million (representing the entire goodwill assigned to this reporting unit). The restructuring charges recorded by the Company are not allocated to its reportable segments. The Company will continue to evaluate its operating footprint, cost structure and strategic opportunities, but does not expect to incur additional material charges related to its fiscal 2023 restructuring initiatives. The following table summarizes the charges resulting from the 2023 restructuring actions (in thousands): Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 3,600 $ 19,183 $ 22,783 Asset impairment costs 43,004 45,422 88,426 Goodwill impairment (see Note 6) — 12,411 12,411 One-time employee termination benefits — 2,885 2,885 Total $ 46,604 $ 79,901 $ 126,505 The asset impairment costs include inventory write-downs (for inventory expected to be disposed of) and equipment impairments (to adjust the carrying value of certain equipment to reflect its fair value). The estimated fair value of the equipment was determined using a market approach based upon quoted market prices from auction data. The significant inputs related to valuing these assets are classified as Level 2 in the fair value measurement hierarchy. The following table summarizes the activity related to the Company's restructuring liabilities for the fiscal year ended April 1, 2023 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of April 2, 2022 $ — $ — $ — Costs incurred and charged to expense 2,885 22,783 25,668 Cash payments (2,885) (17,535) (20,420) Accrued restructuring balance as of April 1, 2023 $ — $ 5,248 $ 5,248 During fiscal years 2022 and 2021, the Company's restructuring charges were $2.1 million and $2.7 million, respectively, primarily related to fiscal 2019 actions to reduce operating expenses and improve manufacturing cost structure.

Income Taxes

Income Taxes	12 Months Ended
	Apr. 01, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income (loss) before income taxes consists of the following components (in thousands): Fiscal Year 2023 2022 2021 United States $ (466,070) $ 69,938 $ 125,362 Foreign 590,699 1,111,146 682,018 Total $ 124,629 $ 1,181,084 $ 807,380 The components of the income tax provision are as follows (in thousands): Fiscal Year 2023 2022 2021 Current tax (expense) benefit: Federal $ (21,704) $ (16,886) $ (11,043) State (488) (274) (140) Foreign (65,430) (98,696) (80,722) (87,622) (115,856) (91,905) Deferred tax (expense) benefit: Federal 60,351 (18,398) (35,545) State 2,371 (2,762) (3,771) Foreign 3,423 (10,715) 57,452 66,145 (31,875) 18,136 Total $ (21,477) $ (147,731) $ (73,769) A reconciliation of the provision for income taxes to income tax expense computed by applying the statutory federal income tax rate to pre-tax income for fiscal years 2023, 2022 and 2021 is as follows (dollars in thousands): Fiscal Year 2023 2022 2021 Amount Percentage Amount Percentage Amount Percentage Income tax expense at statutory federal rate $ (26,172) 21.0 % $ (248,028) 21.0 % $ (169,550) 21.0 % (Increase) decrease resulting from: State benefit (expense), net of federal impact 2,259 (1.8) (1,888) 0.2 (743) 0.1 Tax credits 97,809 (78.5) 118,877 (10.1) 92,532 (11.5) Effect of changes in income tax rate applied to net deferred tax assets (1) (950) 0.8 (25,679) 2.2 22,286 (2.8) Foreign tax rate difference 73,491 (59.0) 148,932 (12.6) 85,851 (10.6) Foreign permanent differences and related items (10,852) 8.7 786 (0.1) 9,026 (1.1) Change in valuation allowance 385 (0.3) 231 (0.1) (1,232) 0.2 Expiration of state and foreign attributes (1,962) 1.6 (3,048) 0.3 (1,656) 0.2 Stock-based compensation (9,036) 7.2 11,148 (0.9) 9,545 (1.2) Tax reserve adjustments (9,437) 7.6 (3,262) 0.3 (9,979) 1.2 U.S. tax on foreign earnings, including GILTI & FDII (2)(3) (128,708) 103.3 (130,874) 11.1 (100,830) 12.5 Permanent reinvestment assertion (402) 0.3 (1,033) 0.1 (8,488) 1.1 Impairments and acquisition related adjustments (5,695) 4.5 (12,198) 1.0 (919) 0.1 Other income tax (expense) benefit (2,207) 1.8 (1,695) 0.1 388 (0.1) $ (21,477) 17.2 % $ (147,731) 12.5 % $ (73,769) 9.1 % (1) In fiscal 2022, the Company negotiated an extension to its tax holiday in Singapore, resulting in the revaluation of its deferred tax assets. As a result, the Company recognized an income tax expense of $26.4 million due to the reduced tax rate, in part from a reversal of the tax benefit recognized in fiscal 2021. In fiscal 2021, the Company completed the restructuring of the Cavendish intellectual property, resulting in the recognition of an income tax benefit of $22.1 million in Singapore. (2) The Global Intangible Low-Taxed Income ("GILTI") and Foreign-Derived Intangible Income ("FDII") provisions became effective for the Company in fiscal 2019, at which time the Company elected to treat taxes due on future GILTI inclusions in U.S. taxable income as a period cost. (3) Beginning in fiscal 2023 and as required by the Tax Cuts and Jobs Act, the Company was required to capitalize and amortize research and development expenses which were previously expensed for U.S. tax purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the basis used for income tax purposes. The deferred income tax assets and liabilities are measured in each taxing jurisdiction using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Significant components of the Company’s net deferred income taxes are as follows (in thousands): April 1, 2023 April 2, 2022 Deferred income tax assets: Research and other tax credits $ 57,048 $ 56,735 Employee benefits 30,309 34,189 Inventories 24,374 11,592 Net operating loss carryforwards 22,189 27,024 Lease liabilities 18,768 17,905 Prepaid expenses 17,360 — Deferred revenue 14,475 — Capitalized research and development expenses 13,794 6,040 Other 15,898 10,332 Total deferred income tax assets 214,215 163,817 Valuation allowance (35,896) (36,281) Total deferred income tax assets, net of valuation allowance $ 178,319 $ 127,536 Deferred income tax liabilities: Intangible assets $ (69,050) $ (79,452) Property and equipment (39,806) (53,425) Accrued tax on unremitted foreign earnings (25,948) (22,988) Right-of-use assets (17,457) (16,591) Other (2,645) (2,884) Total deferred income tax liabilities (154,906) (175,340) Net deferred income tax asset (liability) $ 23,413 $ (47,804) Amounts included in the Consolidated Balance Sheets: Other non-current assets $ 38,060 $ 36,824 Other long-term liabilities (14,647) (84,628) Net deferred income tax asset (liability) $ 23,413 $ (47,804) The Company has recorded a valuation allowance against certain U.S. and foreign deferred tax assets as of April 1, 2023 and April 2, 2022. These valuation allowances were established based upon management's opinion that it is more likely than not (a likelihood of more than 50 percent) that the benefit of these deferred tax assets will not be realized. The valuation allowance against deferred tax assets decreased in fiscal years 2023 and 2022 by $0.4 million and $0.2 million, respectively, and increased in fiscal 2021 by $1.2 million. The components of the change in valuation allowances and ending balances are as follows (in thousands): Fiscal Year 2023 2022 2021 Beginning valuation allowance $ 36,281 $ 36,512 $ 35,280 Domestic net operating losses and credits 583 1,339 2,144 Foreign net operating losses and other deferred tax assets (968) (1,570) (912) Ending valuation allowance $ 35,896 $ 36,281 $ 36,512 Components of ending valuation allowance: Domestic deferred tax assets $ 35,570 $ 34,987 $ 33,647 Foreign deferred tax assets 326 1,294 2,865 Valuation allowance $ 35,896 $ 36,281 $ 36,512 As of April 1, 2023, the Company had federal tax loss carryforwards of approximately $32.1 million that expire in fiscal years 2024 to 2043, if unused, and state tax loss carryforwards of approximately $107.9 million that expire in fiscal years 2024 to 2043, if unused. Federal research credits of $102.8 million expire in fiscal years 2040 to 2043, and state research credits of $68.3 million expire in fiscal years 2024 to 2043. The Company had foreign tax loss carryforwards of $96.4 million, which expire in fiscal years 2024 to 2033, if unused. The utilization of acquired domestic tax assets is subject to certain annual limitations as required under Section 382 of the Internal Revenue Code of 1986, as amended (the "Code") and similar state income tax provisions. The Company has continued to expand its operations and increase its investments in numerous international jurisdictions. These activities expose the Company to taxation in multiple foreign jurisdictions. As a result, management has concluded that it is not permanently reinvested on certain earnings of its foreign subsidiaries which have been subject to U.S. federal taxation. The remainder of the Company's untaxed foreign earnings and historic investments will continue to be permanently reinvested to fund working capital requirements and operations abroad. It is not practical to estimate the additional tax that would be incurred, if any, if the remainder of the permanently reinvested earnings were repatriated. The Company has foreign subsidiaries with tax holiday agreements in Costa Rica and Singapore. The Company’s tax holiday in Costa Rica is set to expire in December 2027. In fiscal 2022, the Company negotiated an extension to its tax holiday in Singapore, which is currently expected to expire in December 2031. Incentives from these countries are subject to the Company meeting certain employment and investment requirements. Relative to the statutory tax rate, income tax expense decreased by $65.5 million (an impact of approximately $0.64 per basic and diluted share) in fiscal 2023 and $128.4 million (an impact of approximately $1.17 and $1.15 per basic and diluted share, respectively) in fiscal 2022 as a result of these agreements. The Company’s gross unrecognized tax benefits totaled $152.3 million, $144.1 million and $134.1 million as of April 1, 2023, April 2, 2022, and April 3, 2021, respectively. Of these amounts, $145.9 million, $137.5 million and $128.7 million as of April 1, 2023, April 2, 2022 and April 3, 2021, respectively, represent the amounts of unrecognized tax benefits that, if recognized, would impact the effective tax rate in each of the fiscal years. The Company’s gross unrecognized tax benefits increased from $144.1 million as of April 2, 2022 to $152.3 million as of April 1, 2023, primarily due to current year tax positions and the effect of provision-to-return adjustments on prior year positions. A summary of the changes in the amount of gross unrecognized tax benefits is as follows (in thousands): Fiscal Year 2023 2022 2021 Beginning balance $ 144,055 $ 134,068 $ 119,222 Additions based on positions related to current year 9,718 11,826 10,048 Additions for tax positions in prior years 2,467 3,049 6,240 Reductions for tax positions in prior years (363) (1,669) (348) Expiration of statute of limitations (3,546) (3,219) (1,094) Settlements — — — Ending balance $ 152,331 $ 144,055 $ 134,068 It is the Company’s policy to recognize interest and penalties related to uncertain tax positions as a component of income tax expense. During fiscal years 2023, 2022 and 2021, the Company recognized $0.9 million, $(5.1) million and $0.8 million, respectively, of interest and penalties related to uncertain tax positions. Accrued interest and penalties related to unrecognized tax benefits totaled $1.9 million, $1.0 million and $6.2 million as of April 1, 2023, April 2, 2022 and April 3, 2021, respectively. The unrecognized tax benefits of $152.3 million and accrued interest and penalties of $1.9 million at the end of fiscal 2023 are recorded on the Consolidated Balance Sheet as a $21.0 million other long-term liability, with the balance reducing the carrying value of the gross deferred tax assets. Due to uncertainties regarding the timing of examinations and the amount of settlements that may be paid, if any, to tax authorities, the Company believes it is reasonably possible that $22.1 million of gross unrecognized tax benefits will be reduced within the next 12 months. The Company files a consolidated U.S. federal income tax return, as well as separate and combined income tax returns in numerous state and international jurisdictions. The Company’s fiscal 2020 U.S. federal and state tax returns and subsequent tax years remain open for examination, as well as all attributes brought forward into those years. The Company is also subject to examination by various international tax authorities. The tax years subject to examination vary by jurisdiction.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Apr. 01, 2023
Earnings Per Share [Abstract]
NET INCOME (LOSS) PER SHARE	NET INCOME PER SHARE The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data): Fiscal Year 2023 2022 2021 Numerator: Numerator for basic and diluted net income per share — net income available to common stockholders $ 103,152 $ 1,033,353 $ 733,611 Denominator: Denominator for basic net income per share — weighted-average shares 102,206 110,196 114,034 Effect of dilutive securities: Stock-based awards 813 1,350 1,982 Denominator for diluted net income per share — adjusted weighted-average shares and assumed conversions 103,019 111,546 116,016 Basic net income per share $ 1.01 $ 9.38 $ 6.43 Diluted net income per share $ 1.00 $ 9.26 $ 6.32 In the computation of diluted net income per share for fiscal 2023, approximately 0.8 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. An immaterial number of shares of outstanding stock-based awards were excluded from the computation of diluted net income per share for fiscal years 2022 and 2021 because the effect of their inclusion would have been antidilutive.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Apr. 01, 2023
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION Summary of Stock Plans 2009 and 2012 Incentive Plans - TriQuint Semiconductor, Inc. Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2009 Incentive Plan and the TriQuint, Inc. 2012 Incentive Plan (the "TriQuint Incentive Plans"), originally adopted by TriQuint. The TriQuint Incentive Plans provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates. No further awards can be granted under these plans. 2012 Stock Incentive Plan - Qorvo, Inc. The 2012 Stock Incentive Plan (the "2012 Plan") was assumed by the Company in connection with the Business Combination and reapproved by the Company's stockholders on August 8, 2017 for purposes of Section 162(m) of the Internal Revenue Code. Under the 2012 Plan, the Company was permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units. The aggregate number of shares subject to performance-based restricted stock units awarded for fiscal 2023 under the 2012 Plan was 0.2 million shares. No further awards can be granted under this plan. 2013 Incentive Plan - Qorvo, Inc. Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2013 Incentive Plan (the "2013 Incentive Plan"), originally adopted by TriQuint, allowing the Company to issue awards under this plan. The 2013 Incentive Plan replaced the TriQuint 2012 Incentive Plan and provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates who were such prior to the Business Combination or who became employed by the Company or its affiliates after the closing of the Business Combination. No further awards can be granted under this plan. 2015 Inducement Stock Plan - Qorvo, Inc. The 2015 Inducement Stock Plan provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock-based awards to persons as a material inducement to become employees of the Company or its affiliates. No further awards can be granted under this plan. 2022 Stock Incentive Plan – Qorvo, Inc. The Company currently grants equity-based awards to eligible employees, directors and independent contractors under the 2022 Stock Incentive Plan (the "2022 Plan"), which was approved by the Company's stockholders on August 9, 2022. Under the 2022 Plan, the Company is permitted to grant awards, such as restricted stock units, restricted stock awards, performance shares, performance units, stock options, stock appreciation rights and phantom stock awards, to eligible participants. The maximum number of shares issuable under the 2022 Plan may not exceed 4.5 million shares (subject to adjustment for anti-dilution purposes). As of April 1, 2023, approximately 4.4 million shares were available for issuance under the 2022 Plan. Employee Stock Purchase Plan - Qorvo, Inc. Effective upon closing of the Business Combination, the Company assumed the TriQuint Employee Stock Purchase Plan (the "ESPP"), which is intended to qualify as an "employee stock purchase plan" under Section 423 of the Internal Revenue Code. All regular full-time employees of the Company (including officers) and all other employees who meet the eligibility requirements of the plan may participate in the ESPP. The ESPP provides eligible employees an opportunity to acquire the Company’s common stock at 85.0% of the lower of the closing price per share of the Company’s common stock on the first or last day of each six-month purchase period. As of April 1, 2023, 2.6 million shares were available for future issuance under this plan. The Company makes no cash contributions to the ESPP, but bears the expenses of its administration. The Company issued 0.3 million shares under the ESPP in fiscal 2023, 0.3 million shares in fiscal 2022 and 0.4 million shares in fiscal 2021. For fiscal years 2023, 2022 and 2021, the primary stock-based awards and their general terms and conditions are as follows: Restricted stock units granted by the Company in fiscal years 2023, 2022 and 2021 are either service-based or performance and service-based. Service-based restricted stock units generally vest over a four two The options and restricted stock units granted to certain officers of the Company generally will, in the event of the officer's termination other than for cause and subject to the officer executing certain agreements in favor of the Company, continue to vest pursuant to the same vesting schedule as if the officer had remained an employee of the Company and, as a result, these awards are expensed at grant date. In fiscal 2023, stock-based compensation of $28.5 million was recognized upon the grant of 0.3 million restricted share units to certain officers of the Company. Stock-Based Compensation Under ASC 718, stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. ASC 718 covers a wide range of stock-based compensation arrangements including stock options, restricted share plans, performance-based awards, share appreciation rights and employee stock purchase plans. Total pre-tax stock-based compensation expense recognized in the Consolidated Statements of Income was $105.6 million, $83.5 million and $89.3 million, for fiscal years 2023, 2022 and 2021, respectively, net of expense capitalized into inventory. A summary of activity with respect to stock options under the Company’s director and employee stock plans follows: Options Weighted- Weighted-Average Remaining Contractual Term (in years) Aggregate Outstanding as of April 2, 2022 258 $ 15.67 Granted — — Exercised (187) $ 13.74 Canceled (2) $ 14.19 Forfeited — — Outstanding as of April 1, 2023 69 $ 20.95 0.35 $ 5,562 Vested and expected to vest as of April 1, 2023 69 $ 20.95 0.35 $ 5,562 Options exercisable as of April 1, 2023 69 $ 20.95 0.35 $ 5,562 The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based upon the Company’s closing stock price of $101.57 as of March 31, 2023 (the last Nasdaq trading day prior to the fiscal year end on April 1, 2023), that would have been received by the option holders had all option holders with in-the-money options exercised their options as of that date. As of April 1, 2023, there was no remaining unearned compensation cost related to unvested option awards. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model based on the historical volatility, dividend yield, term and risk-free interest rate. There were no options granted during fiscal years 2023, 2022 and 2021. The total intrinsic value of options exercised during fiscal years 2023, 2022 and 2021 was $16.5 million, $27.1 million and $66.7 million, respectively. Cash received from the exercise of stock options and from participation in the employee stock purchase plan (excluding accrued unremitted employee funds) was approximately $32.7 million for fiscal 2023 and is reflected in cash flows from financing activities in the Consolidated Statement of Cash Flows. The Company settles employee stock options with newly issued shares of the Company's common stock. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based upon historical pre-vesting forfeiture experience, the Company assumed an annualized forfeiture rate of 1.4% for both stock options and restricted stock units. A summary of activity with respect to restricted stock units ( " RSUs " ) awarded under the Company’s director and employee stock plans follows: RSUs Weighted-Average Balance as of April 2, 2022 1,539 $ 126.46 Granted 1,125 104.16 Vested (703) 111.85 Forfeited (129) 122.08 Balance as of April 1, 2023 1,832 $ 118.38 As of April 1, 2023, total remaining unearned compensation cost related to unvested restricted stock units was $137.6 million, which will be amortized over the weighted-average remaining service period of approximately 1.3 years. The total intrinsic value of restricted stock units that vested during fiscal years 2023, 2022 and 2021 was $74.1 million, $163.6 million and $121.8 million, respectively, based upon the fair market value of the Company’s

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Apr. 01, 2023
Equity [Abstract]
SHAREHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Stock Repurchase On November 2, 2022, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice. As of January 1, 2023, the Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the IRA. The excise tax is recognized as part of the cost basis of shares acquired in the Consolidated Statements of Stockholders' Equity. During fiscal years 2023, 2022 and 2021, the Company repurchased approximately 8.7 million shares, 7.3 million shares and 3.6 million shares of its common stock, respectively, for approximately $862.2 million, $1,152.3 million and $515.1 million, respectively (including transaction costs and excise tax, as applicable) under the prior and current share repurchase programs. As of April 1, 2023, approximately $1,705.0 million remains available for repurchases under the current share repurchase program. Common Stock Reserved For Future Issuance As of April 1, 2023, the Company had reserved a total of approximately 8.9 million of its authorized 405.0 million shares of common stock for future issuance as follows (in thousands): Outstanding stock options under formal directors’ and employees’ stock option plans 69 Possible future issuance under Company stock incentive plans 4,398 Employee stock purchase plan 2,639 Restricted stock-based units outstanding 1,832 Total shares reserved 8,938

Operating Segment and Geographi

Operating Segment and Geographical Information	12 Months Ended
	Apr. 01, 2023
Segment Reporting [Abstract]
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION	OPERATING SEGMENT AND GEOGRAPHIC INFORMATION In the second quarter of fiscal 2023, the Company updated its organizational structure to more closely align technologies and applications with customers and end markets. Prior to this organizational change, the Company operated under two segments (MP and IDP) and subsequent to this organizational change, the Company is operating under three segments (HPA, CSG and ACG). The Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"), allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. All prior-period segment data has been adjusted to reflect these three operating segments. HPA is a leading global supplier of RF and power solutions for automotive, defense and aerospace, cellular infrastructure, broadband and other markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and 5G deployments outside of China. CSG is a leading global supplier of connectivity and sensor solutions, with broad expertise spanning UWB, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things, MEMS-based sensors and BAW-based sensors. CSG combines the connectivity and sensors businesses formerly split between MP and IDP. CSG’s markets include smart home, industrial automation, automotive, smartphones, wearables, gaming, and industrial and enterprise access points. ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies. ACG is a highly diversified supplier of custom and open market cellular solutions, serving iOS and Android original equipment manufacturers. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring related charges, acquisition and integration related costs, charges associated with a long-term capacity reservation agreement, goodwill impairment, fixed asset impairments, (loss) gain on sale of fixed assets, start-up costs and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other (expense) income, or taxes to operating segments. Except as discussed above regarding the "All other" category, the Company's accounting policies for segment reporting are the same as for the Company as a whole. The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Fiscal Year 2023 2022 2021 Revenue: HPA $ 727,187 $ 707,395 $ 803,320 CSG 474,364 703,881 653,445 ACG 2,367,848 3,234,438 2,558,542 Total revenue $ 3,569,399 $ 4,645,714 $ 4,015,307 Operating income (loss): HPA $ 198,820 $ 210,441 $ 256,529 CSG (72,080) 107,814 66,576 ACG 627,708 1,233,388 968,573 All other (571,280) (325,574) (385,051) Operating income 183,168 1,226,069 906,627 Interest expense (68,463) (63,326) (75,198) Other income (expense), net 9,924 18,341 (24,049) Income before income taxes $ 124,629 $ 1,181,084 $ 807,380 . Fiscal Year 2023 2022 2021 Reconciliation of "All other" category: Stock-based compensation expense $ (105,580) $ (83,507) $ (89,322) Amortization of intangible assets (132,126) (150,128) (252,137) Restructuring related charges (114,094) (2,121) (2,722) Acquisition and integration related costs (23,311) (27,964) (32,946) Charges associated with a long-term capacity reservation agreement (1) (181,000) — — Goodwill impairment (12,411) (48,000) — Other (2) (2,758) (13,854) (7,924) Loss from operations for "All other" $ (571,280) $ (325,574) $ (385,051) (1) Refer to Note 11 for additional information. (2) Other includes fixed asset impairments, (loss) gain on sale of fixed assets, start-up costs and other miscellaneous corporate overhead expenses. The consolidated financial statements include revenue to customers by geographic region (based on the location of the customers' headquarters) that are summarized as follows (in thousands): Fiscal Year 2023 2022 2021 Revenue: United States $ 1,817,960 $ 1,928,403 $ 1,631,110 China 741,405 1,499,212 1,579,017 Other Asia 498,966 620,620 363,523 Taiwan 308,642 345,869 248,708 Europe 202,426 251,610 192,949 Total Revenue $ 3,569,399 $ 4,645,714 $ 4,015,307 The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands): April 1, 2023 April 2, 2022 Long-lived tangible assets: United States $ 928,428 $ 1,007,463 China 169,215 192,416 Other countries 51,145 53,712

The Company and Its Significa_2

The Company and Its Significant Accounting Policies (Policies)	12 Months Ended
	Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts (including prior period segment results) have been reclassified to conform to the fiscal 2023 presentation.
Accounting Periods	Accounting Periods The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on April 1, 2023, April 2, 2022 and April 3, 2021. Fiscal years 2023 and 2022 were 52-week years, and fiscal 2021 was a 53-week year.
Use of Estimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the disclosure of contingent liabilities. The Company evaluates its estimates on an ongoing basis, including those related to revenue recognition, product warranty obligations, valuation of inventories, tax related contingencies, valuation of long-lived and intangible assets, other contingencies and litigation, among others. The Company generally bases its estimates on historical experience, expected future conditions and third-party evaluations. The inputs into certain of these estimates and assumptions include the consideration of the impact of the COVID-19 pandemic and other macroeconomic factors. Actual results could differ materially from these estimates, and such differences could affect the operations reported in future periods.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly liquid investments with original maturities of three months or less when purchased.
Investments	Investments Marketable equity securities consist of common stock in publicly traded companies and are carried at fair value with both the realized and unrealized gains and losses reported in "Other income (expense), net." Fair values of publicly traded equity securities are determined using quoted prices in active markets. The marketable equity securities are classified as short-term based on their highly liquid nature and are recorded in "Other current assets" in the Consolidated Balance Sheets. The Company invests in limited partnerships which are accounted for using the equity method. These equity method investments are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company records its share of the financial results of the limited partnerships in "Other income (expense), net" in the Company's Consolidated Statements of Income. The Company also invests in privately held companies for which the fair value of the investment is not readily determinable. These equity investments without a readily determinable fair value are measured at cost less impairment, adjusted for any changes in observable prices, and are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company assesses these investments for impairment on a quarterly basis and considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include the investee's financial condition and business outlook, market for technology and other relevant events and factors affecting the investee. Investments are impaired when their fair value is less than their carrying value.
Fair Value Measurement	Fair Value Measurement The Company measures and reports certain financial assets and liabilities on a recurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is described as follows: • Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly, and fair value can be determined through the use of models or other valuation methodologies that do not require significant judgment since the inputs are corroborated by readily observable data. • Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment. The Company also holds assets whose fair value is measured and recorded on a nonrecurring basis. These assets include equity method investments, equity investments without a readily determinable fair value and certain non-financial assets, such as intangible assets and property and equipment. The carrying values of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). Cost includes labor, materials and manufacturing overhead related to the purchase and production of inventories. In accordance with Accounting Standards Codification ("ASC") 330, "Inventory" ("ASC 330"), abnormal manufacturing costs are charged to "Cost of goods sold" in the period incurred rather than as a portion of inventory cost. The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against demand forecasts on a material or product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of demand forecasts and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered
Product Warranty	Product Warranty The Company generally sells products with a limited warranty against defects in materials and workmanship and non-conformance to applicable specifications. The majority of the Company’s product warranty claims are settled through the return of the defective product and the shipment of replacement product. Accruals are estimated based upon both historical experience as well as specifically identified claims. If there is a significant increase in the rate of customer claims compared with the Company's historical experience or if the Company's estimates of probable losses relating to specifically identified warranty exposures require revision, the Company may record a charge against future cost of sales. Product warranty accruals and related expenses were immaterial for the periods presented.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held and used by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as "held for sale" are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.
Lessee, Leases [Policy Text Block]	Leases The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, the Company assesses whether it has the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset. Right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes renewal options when it is reasonably certain that the option will be exercised and excludes termination options. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. The Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In
Business Combinations Policy [Policy Text Block]	Business Acquisitions The Company allocates the fair value of the purchase price to the assets acquired and liabilities assumed based on their estimated fair value. The excess of the purchase price over the fair values of the identifiable assets and liabilities is recorded to goodwill. Goodwill is assigned to the Company's reporting unit that is expected to benefit from the synergies of the business combination. A number of assumptions, estimates and judgments are used in determining the fair value of acquired assets and liabilities, particularly with respect to the intangible assets acquired. The valuation of intangible assets requires the Company to use valuation techniques such as the income approach. The income approach includes management’s estimation of future cash flows (including expected revenue growth rates and profitability), the underlying product or technology life cycles and the discount rates applied to future cash flows. Judgment is also required in estimating the fair values of deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date, as well as inventory, property and equipment, pre-existing liabilities or legal claims, deferred revenue and contingent consideration, each as may be applicable. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the measurement period, any purchase price adjustments are recognized in the Consolidated Statement of Income.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Impairment Testing In accordance with ASC 350, " Intangibles - Goodwill and Other " ("ASC 350"), goodwill is not amortized, but rather is reviewed for impairment at the reporting unit level on the first day of the Company's fourth quarter of each fiscal year, or when there is evidence that events or changes in circumstances indicate that the carrying amount of the goodwill may not be recovered. Under ASC 350, the Company has the option to first assess qualitatively whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. In performing qualitative assessments, the Company considers (i) its overall historical and projected future operating results, (ii) if there was a significant decline in its stock price for a sustained period, (iii) if there was a significant change in its market capitalization relative to its net book value, and (iv) if there was a prolonged or more significant slowdown in the worldwide economy of the semiconductor industry, as well as other relevant events and factors affecting the reporting unit. If qualitative assessments conclude that it is more likely than not that the fair value of any reporting unit is less than its carrying value, quantitative assessments are performed on the applicable reporting units. The quantitative assessments consider both the income and market approaches to estimate the fair value of a reporting unit. The income approach is based on the discounted cash flow method that uses estimates of the reporting unit's forecasted future financial performance including revenue, operating expenses, taxes and capital expenditures. These estimates are developed as part of the Company's long-term planning process based on assumed market segment growth rates and its assumed market segment share, estimated costs based on historical data and various internal estimates. Projected cash flows are then discounted to a present value employing a discount rate that properly accounts for the estimated market weighted-average cost of capital, as well as any risk unique to the cash flows. The market approach is based on financial multiples (i.e., multiples of revenue or earnings before income taxes, depreciation and amortization) of comparable companies. Refer to Note 6 for additional information regarding goodwill and intangible asset impairment testing.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Identified Intangible Assets The Company amortizes definite-lived intangible assets (including developed technology, customer relationships, technology licenses, backlog and trade names) over their estimated useful lives. IPRD assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of the acquisition and are initially not subject to amortization. Upon completion of development, IPRD assets are transferred to developed technology and are amortized over their useful lives. The asset balances relating to abandoned projects are impaired and expensed to R&D. The Company evaluates definite-lived intangible assets for impairment in accordance with ASC 360-10-35, " Impairment or Disposal of Long-Lived Assets " to determine whether facts and circumstances (including external factors such as industry and economic trends and internal factors such as changes in the Company’s business strategy and forecasts) indicate that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amounts over the fair value of those assets and occur in the period in which the impairment determination was made.
Revenue Recognition	Revenue Recognition The Company generates revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, or at completion of a consignment process. Revenue is recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. A majority of the Company's revenue is recognized at a point in time, either on shipment or delivery of the product, depending on individual customer terms and conditions. Revenue from sales to the Company’s distributors is recognized upon shipment of the product to the distributors (sell-in). Revenue is recognized from the Company’s consignment programs at a point in time when the products are pulled from consignment inventory by the customer. Revenue recognized for products and services over time is less than 4% of overall revenue. The Company applies a five-step approach as defined in ASC 606, " Revenue from Contracts with Customers, " in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when the corresponding performance obligation is satisfied. Sales agreements are in place with certain customers and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require minimum purchase commitments. In the absence of a sales agreement, the Company’s standard terms and conditions apply. The Company considers a customer's purchase order, which is governed by a sales agreement or the Company’s standard terms and conditions, to be the contract with the customer. The Company’s pricing terms are negotiated independently, on a stand-alone basis. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Variable consideration in the form of rebate programs is offered to certain customers, including distributors, and represents less than 7% of net revenue. The Company determines variable consideration by estimating the most likely amount of consideration it expects to receive from the customer. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company may authorize sales returns under certain circumstances, which include courtesy returns and like-kind exchanges. The Company reduces revenue and records reserves for product returns and allowances, rebate programs and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company’s accounts receivable balance is from contracts with customers and represents the Company’s unconditional right to receive consideration from its customers. Payments are due upon completion of the performance obligation and subsequent invoicing. Substantially all payments are collected within the Company’s standard terms, which do not include any financing components. There have been no material impairment losses on accounts receivable for fiscal years 2023, 2022 or 2021. Contract assets and contract liabilities recorded on the Consolidated Balance Sheets were immaterial as of April 1, 2023 and April 2, 2022. The Company invoices customers upon shipment and recognizes revenue in accordance with delivery terms. As of April 1, 2023, the Company had $167.8 million in remaining unsatisfied performance obligations with an original duration greater than one year, of which the majority is expected to be recognized as income over the next 12 months. The Company includes shipping charges billed to customers in "Revenue" and includes the related shipping costs in "Cost of goods sold" in the Consolidated Statements of Income. Taxes assessed by government authorities on revenue-producing transactions, including tariffs, value-added and excise taxes, are excluded from revenue in the Consolidated Statements of Income. The Company incurs commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded in the "Selling, general and administrative" expense line item in the Consolidated Statements of Income) are expensed when incurred because such commissions are not owed until the performance obligation is satisfied, which coincides with the end of the contract term, and therefore, no remaining period exists over which to amortize the commissions.
Research and Development	Research and Development The Company charges all R&D costs to expense as incurred.
Income Taxes	Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more-likely-than-not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. It is the Company’s current intent and policy to repatriate certain previously taxed earnings of foreign subsidiaries from outside the U.S. Accordingly, the Company recognizes a deferred tax liability for income taxes on certain unremitted foreign earnings of foreign subsidiaries. For earnings which remain permanently reinvested, it is not practical to estimate the additional tax that would be incurred, if any, if the permanently reinvested earnings were repatriated.
Stock-Based Compensation	Stock-Based Compensation Under ASC 718, " Compensation – Stock Compensation, " stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of April 1, 2023, total remaining unearned compensation cost related to unvested restricted stock units was $137.6 million, which will be amortized over the weighted-average remaining service period of approximately 1.3 years.
Foreign Currency Translation	Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with ASC 830, " Foreign Currency Matters. " The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenue and expenses are translated using the weighted-average exchange rates throughout the year. Translation adjustments are shown separately as a component of "Accumulated other comprehensive (loss) income" within "Stockholders’ equity" in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in "Other income (expense), net" in the Consolidated Statements of Income.
Recent Accounting Pronouncements	Recent Accounting Pronouncements and Other Developments In November 2021, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2021-10, "Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance " to increase transparency about certain government assistance or grants received by a business entity. This new guidance requires the disclosure of (1) the types of assistance, (2) an entity's accounting for the assistance, and (3) the effect of the assistance on an entity's financial statements. The Company adopted ASU 2021-10 on April 3, 2022. From time to time, the Company receives cash grants and tax abatements from U.S. federal and state governments and non-U.S. governments which, in most cases, attach conditions for a specific duration period and generally relate to hiring employees, the construction or acquisition of assets or to developing specific technologies. If conditions are not satisfied, or the duration period for the agreement is infringed, the incentives are subject to reduction, termination, or recapture. The Company's accounting policy is to recognize a benefit to the income statement over the duration of the program when the conditions, including the required spending attached to the incentive are achieved and the Company is expected to complete any further requirements. A grant that compensates for operational expenses is recognized as a reduction from the nature of the expense the grant is designated to offset. A grant related to property, plant and equipment investments is recognized as a reduction to the cost-basis of the underlying assets with an ongoing reduction to depreciation expense based on the useful lives of the related assets. During fiscal 2023, the Company received a nominal amount related to these programs. In August 2022, the Creating Helpful Incentives to Produce Semiconductors and Science Act (the "CHIPS Act") was signed into law. The CHIPS Act provides for a 25% refundable tax credit on certain investments in domestic semiconductor manufacturing. The credit is provided for qualifying property, which is placed in service after December 31, 2022. The CHIPS Act also provides for certain other financial incentives to further investments in domestic semiconductor manufacturing. The Company is evaluating the provisions of the new law and its potential impact to the Company. In August 2022, the Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new book minimum tax of 15% on consolidated adjusted GAAP pre-tax earnings for corporations with average income in excess of $1 billion and is effective for tax years beginning after December 31, 2022. In addition, the IRA also introduced a nondeductible 1% excise tax on a publicly traded corporation for the net value of certain stock
Supplemental financial information	Supplemental Financial Information The "Accrued liabilities" balance as of April 1, 2023 and April 2, 2022, includes accrued compensation and benefits of $92.9 million and $113.6 million, respectively, and accrued rebates of $42.8 million and $33.1 million, respectively. The "Other current liabilities" balance as of April 1, 2023 includes income taxes payable of $63.6 million and contingent consideration related to the acquisition of United Silicon Carbide, Inc. ("United SiC") of $31.3 million. The "Other current liabilities" balances as of April 2, 2022 includes income taxes payable of $87.8 million.

Operating Segment and Geograp_2

Operating Segment and Geographic Information Policies (Policies)	12 Months Ended
	Apr. 01, 2023
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	In the second quarter of fiscal 2023, the Company updated its organizational structure to more closely align technologies and applications with customers and end markets. Prior to this organizational change, the Company operated under two segments (MP and IDP) and subsequent to this organizational change, the Company is operating under three segments (HPA, CSG and ACG). The Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"), allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. All prior-period segment data has been adjusted to reflect these three operating segments.

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Apr. 01, 2023
Inventory Disclosure [Abstract]
Components of inventories	The components of inventories, net of reserves, are as follows (in thousands): April 1, 2023 April 2, 2022 Raw materials $ 264,367 $ 236,095 Work in process 345,545 357,332 Finished goods 186,684 162,321 Total inventories $ 796,596 $ 755,748

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Apr. 01, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	The components of property and equipment are as follows (in thousands): April 1, 2023 April 2, 2022 Land $ 25,842 $ 25,842 Building and leasehold improvements 463,888 432,305 Machinery and equipment 2,430,307 2,401,735 Construction in progress 130,086 128,317 Total property and equipment, gross 3,050,123 2,988,199 Less accumulated depreciation (1,900,317) (1,734,608) Total property and equipment, net $ 1,149,806 $ 1,253,591

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Apr. 01, 2023
Indefinite-lived Intangible Assets [Line Items]
Schedule of Goodwill [Table Text Block]	The changes in the carrying amount of goodwill for fiscal 2023 are as follows (in thousands): HPA CSG ACG Total Balance as of April 2, 2022 (1) $ 501,899 $ 539,875 $ 1,733,860 $ 2,775,634 NextInput measurement period adjustments — 572 — 572 United SiC measurement period adjustments (297) — — (297) Goodwill impairment — (12,411) — (12,411) Effect of changes in foreign currency exchange rates — (2,685) — (2,685) Balance as of April 1, 2023 (1) $ 501,602 $ 525,351 $ 1,733,860 $ 2,760,813
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table Text Block]	The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): April 1, 2023 April 2, 2022 Gross Accumulated Gross Accumulated Developed technology $ 872,106 $ 382,448 $ 1,026,690 $ 420,255 Customer relationships 104,616 67,485 104,778 47,208 Technology licenses 1,664 513 2,641 2,169 Trade names 910 789 1,933 1,358 IPRD 9,642 N/A 9,734 N/A Total (1) $ 988,938 $ 451,235 $ 1,145,776 $ 470,990 (1) Amounts include the impact of foreign currency translation.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	The following table provides the Company's estimated amortization expense for intangible assets for the periods indicated (in thousands): Fiscal Year Estimated 2024 $ 121,000 2025 105,000 2026 95,000 2027 82,000 2028 54,000

Investments and Fair Value Me_2

Investments and Fair Value Measurements (Tables)	12 Months Ended
	Apr. 01, 2023
Schedule of available-for-sale debt securities
Fair value of the financial assets measured at fair value on a recurring basis	The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands): Total Quoted Prices In Significant Other Significant April 1, 2023 Marketable equity securities $ 1,094 $ 1,094 $ — $ — Invested funds in deferred compensation plan (1) 40,653 40,653 — — Contingent earn-out liability (2) (31,250) — — (31,250) April 2, 2022 Marketable equity securities $ 2,906 $ 2,906 $ — $ — Invested funds in deferred compensation plan (1) 39,356 39,356 — — Contingent earn-out liability (2) (17,600) — — (17,600) (1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share as determined by quoted active market prices of the underlying investments. Refer to Note 10 for further information on the Company's non-qualified deferred compensation plan. (2) The fair value of the contingent consideration liability which related to the acquisition of United SiC (refer to Note 5 ) was equal to the maximum amount payable at April 1, 2023 and was estimated using an option pricing model at April 2, 2022.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Apr. 01, 2023
Leases [Abstract]
Schedule of supplemental balance sheet information related to operating leases [Table Text Block]	Operating leases are classified as follows (in thousands): April 1, 2023 April 2, 2022 Other non-current assets $ 83,490 $ 73,683 Other current liabilities 19,357 17,393 Other long-term liabilities 69,156 61,511
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	The aggregate future lease payments for operating leases as of April 1, 2023 are as follows (in thousands): Fiscal Year Lease Payments 2024 $ 22,037 2025 17,516 2026 15,270 2027 12,350 2028 11,270 Thereafter 21,150 Total future lease payments 99,593 Less imputed interest (11,080) Present value of lease liabilities $ 88,513
Lease, Cost	Details of operating leases are as follows (in thousands): Fiscal Year 2023 2022 2021 Operating lease expense $ 20,162 $ 19,178 $ 17,382 Short-term lease expense 7,798 7,726 7,062 Variable lease expense 5,386 4,886 3,972 Cash paid for amounts included in the measurement of operating lease liabilities 21,480 20,536 18,697 Right-of-use assets obtained in exchange for new operating lease liabilities 28,940 29,210 12,899
Lessee, Operating Lease, Disclosure	The weighted-average remaining lease term and weighted-average discount rate for operating leases are as follows: April 1, 2023 April 2, 2022 Weighted-average remaining lease term (years) 6.5 6.9 Weighted-average discount rate 3.98 % 2.99 %

Debt (Tables)

Debt (Tables)	12 Months Ended
	Apr. 01, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt is as follows (in thousands): April 1, 2023 April 2, 2022 1.750% senior notes due 2024 $ 500,000 $ 500,000 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Finance leases and other 1,666 2,581 Unamortized premium, discount and issuance costs, net (3,283) (4,692) Less current portion of long-term debt (310) (791) Total long-term debt $ 2,048,073 $ 2,047,098

Restructuring Tables (Tables)

Restructuring Tables (Tables)	12 Months Ended
	Apr. 01, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs [Table Text Block]	The following table summarizes the charges resulting from the 2023 restructuring actions (in thousands): Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 3,600 $ 19,183 $ 22,783 Asset impairment costs 43,004 45,422 88,426 Goodwill impairment (see Note 6) — 12,411 12,411 One-time employee termination benefits — 2,885 2,885 Total $ 46,604 $ 79,901 $ 126,505 The asset impairment costs include inventory write-downs (for inventory expected to be disposed of) and equipment impairments (to adjust the carrying value of certain equipment to reflect its fair value). The estimated fair value of the equipment was determined using a market approach based upon quoted market prices from auction data. The significant inputs related to valuing these assets are classified as Level 2 in the fair value measurement hierarchy.
Restructuring Liabilities Rollforward	The following table summarizes the activity related to the Company's restructuring liabilities for the fiscal year ended April 1, 2023 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of April 2, 2022 $ — $ — $ — Costs incurred and charged to expense 2,885 22,783 25,668 Cash payments (2,885) (17,535) (20,420) Accrued restructuring balance as of April 1, 2023 $ — $ 5,248 $ 5,248

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Apr. 01, 2023
Income Tax Disclosure [Abstract]
Income before income taxes	Income (loss) before income taxes consists of the following components (in thousands): Fiscal Year 2023 2022 2021 United States $ (466,070) $ 69,938 $ 125,362 Foreign 590,699 1,111,146 682,018 Total $ 124,629 $ 1,181,084 $ 807,380
Components of the income tax (provision) benefit	The components of the income tax provision are as follows (in thousands): Fiscal Year 2023 2022 2021 Current tax (expense) benefit: Federal $ (21,704) $ (16,886) $ (11,043) State (488) (274) (140) Foreign (65,430) (98,696) (80,722) (87,622) (115,856) (91,905) Deferred tax (expense) benefit: Federal 60,351 (18,398) (35,545) State 2,371 (2,762) (3,771) Foreign 3,423 (10,715) 57,452 66,145 (31,875) 18,136 Total $ (21,477) $ (147,731) $ (73,769)
Reconciliation of the (provision for) or benefit from income taxes to income tax(expense) or benefit computed by applying the statutory federal income tax rate to pre-tax income.	A reconciliation of the provision for income taxes to income tax expense computed by applying the statutory federal income tax rate to pre-tax income for fiscal years 2023, 2022 and 2021 is as follows (dollars in thousands): Fiscal Year 2023 2022 2021 Amount Percentage Amount Percentage Amount Percentage Income tax expense at statutory federal rate $ (26,172) 21.0 % $ (248,028) 21.0 % $ (169,550) 21.0 % (Increase) decrease resulting from: State benefit (expense), net of federal impact 2,259 (1.8) (1,888) 0.2 (743) 0.1 Tax credits 97,809 (78.5) 118,877 (10.1) 92,532 (11.5) Effect of changes in income tax rate applied to net deferred tax assets (1) (950) 0.8 (25,679) 2.2 22,286 (2.8) Foreign tax rate difference 73,491 (59.0) 148,932 (12.6) 85,851 (10.6) Foreign permanent differences and related items (10,852) 8.7 786 (0.1) 9,026 (1.1) Change in valuation allowance 385 (0.3) 231 (0.1) (1,232) 0.2 Expiration of state and foreign attributes (1,962) 1.6 (3,048) 0.3 (1,656) 0.2 Stock-based compensation (9,036) 7.2 11,148 (0.9) 9,545 (1.2) Tax reserve adjustments (9,437) 7.6 (3,262) 0.3 (9,979) 1.2 U.S. tax on foreign earnings, including GILTI & FDII (2)(3) (128,708) 103.3 (130,874) 11.1 (100,830) 12.5 Permanent reinvestment assertion (402) 0.3 (1,033) 0.1 (8,488) 1.1 Impairments and acquisition related adjustments (5,695) 4.5 (12,198) 1.0 (919) 0.1 Other income tax (expense) benefit (2,207) 1.8 (1,695) 0.1 388 (0.1) $ (21,477) 17.2 % $ (147,731) 12.5 % $ (73,769) 9.1 % (1) In fiscal 2022, the Company negotiated an extension to its tax holiday in Singapore, resulting in the revaluation of its deferred tax assets. As a result, the Company recognized an income tax expense of $26.4 million due to the reduced tax rate, in part from a reversal of the tax benefit recognized in fiscal 2021. In fiscal 2021, the Company completed the restructuring of the Cavendish intellectual property, resulting in the recognition of an income tax benefit of $22.1 million in Singapore. (2) The Global Intangible Low-Taxed Income ("GILTI") and Foreign-Derived Intangible Income ("FDII") provisions became effective for the Company in fiscal 2019, at which time the Company elected to treat taxes due on future GILTI inclusions in U.S. taxable income as a period cost. (3) Beginning in fiscal 2023 and as required by the Tax Cuts and Jobs Act, the Company was required to capitalize and amortize research and development expenses which were previously expensed for U.S. tax purposes.
Significant components of net deferred income taxes	Significant components of the Company’s net deferred income taxes are as follows (in thousands): April 1, 2023 April 2, 2022 Deferred income tax assets: Research and other tax credits $ 57,048 $ 56,735 Employee benefits 30,309 34,189 Inventories 24,374 11,592 Net operating loss carryforwards 22,189 27,024 Lease liabilities 18,768 17,905 Prepaid expenses 17,360 — Deferred revenue 14,475 — Capitalized research and development expenses 13,794 6,040 Other 15,898 10,332 Total deferred income tax assets 214,215 163,817 Valuation allowance (35,896) (36,281) Total deferred income tax assets, net of valuation allowance $ 178,319 $ 127,536 Deferred income tax liabilities: Intangible assets $ (69,050) $ (79,452) Property and equipment (39,806) (53,425) Accrued tax on unremitted foreign earnings (25,948) (22,988) Right-of-use assets (17,457) (16,591) Other (2,645) (2,884) Total deferred income tax liabilities (154,906) (175,340) Net deferred income tax asset (liability) $ 23,413 $ (47,804) Amounts included in the Consolidated Balance Sheets: Other non-current assets $ 38,060 $ 36,824 Other long-term liabilities (14,647) (84,628) Net deferred income tax asset (liability) $ 23,413 $ (47,804)
Reconciliation of gross unrecognized tax benefits	A summary of the changes in the amount of gross unrecognized tax benefits is as follows (in thousands): Fiscal Year 2023 2022 2021 Beginning balance $ 144,055 $ 134,068 $ 119,222 Additions based on positions related to current year 9,718 11,826 10,048 Additions for tax positions in prior years 2,467 3,049 6,240 Reductions for tax positions in prior years (363) (1,669) (348) Expiration of statute of limitations (3,546) (3,219) (1,094) Settlements — — — Ending balance $ 152,331 $ 144,055 $ 134,068
Summary of Valuation Allowance	The components of the change in valuation allowances and ending balances are as follows (in thousands): Fiscal Year 2023 2022 2021 Beginning valuation allowance $ 36,281 $ 36,512 $ 35,280 Domestic net operating losses and credits 583 1,339 2,144 Foreign net operating losses and other deferred tax assets (968) (1,570) (912) Ending valuation allowance $ 35,896 $ 36,281 $ 36,512 Components of ending valuation allowance: Domestic deferred tax assets $ 35,570 $ 34,987 $ 33,647 Foreign deferred tax assets 326 1,294 2,865 Valuation allowance $ 35,896 $ 36,281 $ 36,512

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Apr. 01, 2023
Earnings Per Share [Abstract]
Reconciliation of the numerators and denominators in the computation of basic and diluted net income (loss) per share	The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data): Fiscal Year 2023 2022 2021 Numerator: Numerator for basic and diluted net income per share — net income available to common stockholders $ 103,152 $ 1,033,353 $ 733,611 Denominator: Denominator for basic net income per share — weighted-average shares 102,206 110,196 114,034 Effect of dilutive securities: Stock-based awards 813 1,350 1,982 Denominator for diluted net income per share — adjusted weighted-average shares and assumed conversions 103,019 111,546 116,016 Basic net income per share $ 1.01 $ 9.38 $ 6.43 Diluted net income per share $ 1.00 $ 9.26 $ 6.32

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Apr. 01, 2023
Share-Based Payment Arrangement [Abstract]
Summary of activity of the Company's director and employee stock option plans	A summary of activity with respect to stock options under the Company’s director and employee stock plans follows: Options Weighted- Weighted-Average Remaining Contractual Term (in years) Aggregate Outstanding as of April 2, 2022 258 $ 15.67 Granted — — Exercised (187) $ 13.74 Canceled (2) $ 14.19 Forfeited — — Outstanding as of April 1, 2023 69 $ 20.95 0.35 $ 5,562 Vested and expected to vest as of April 1, 2023 69 $ 20.95 0.35 $ 5,562 Options exercisable as of April 1, 2023 69 $ 20.95 0.35 $ 5,562
Restricted share plans	RSUs Weighted-Average Balance as of April 2, 2022 1,539 $ 126.46 Granted 1,125 104.16 Vested (703) 111.85 Forfeited (129) 122.08 Balance as of April 1, 2023 1,832 $ 118.38

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Apr. 01, 2023
Equity [Abstract]
Common stock reserved for future issuance	As of April 1, 2023, the Company had reserved a total of approximately 8.9 million of its authorized 405.0 million shares of common stock for future issuance as follows (in thousands): Outstanding stock options under formal directors’ and employees’ stock option plans 69 Possible future issuance under Company stock incentive plans 4,398 Employee stock purchase plan 2,639 Restricted stock-based units outstanding 1,832 Total shares reserved 8,938

Operating Segment and Geograp_3

Operating Segment and Geographical Information (Tables)	12 Months Ended
	Apr. 01, 2023
Segment Reporting [Abstract]
Sales to customers by geographic region	The consolidated financial statements include revenue to customers by geographic region (based on the location of the customers' headquarters) that are summarized as follows (in thousands): Fiscal Year 2023 2022 2021 Revenue: United States $ 1,817,960 $ 1,928,403 $ 1,631,110 China 741,405 1,499,212 1,579,017 Other Asia 498,966 620,620 363,523 Taiwan 308,642 345,869 248,708 Europe 202,426 251,610 192,949 Total Revenue $ 3,569,399 $ 4,645,714 $ 4,015,307
Long-lived assets by geographic region	The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands): April 1, 2023 April 2, 2022 Long-lived tangible assets: United States $ 928,428 $ 1,007,463 China 169,215 192,416 Other countries 51,145 53,712
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Fiscal Year 2023 2022 2021 Revenue: HPA $ 727,187 $ 707,395 $ 803,320 CSG 474,364 703,881 653,445 ACG 2,367,848 3,234,438 2,558,542 Total revenue $ 3,569,399 $ 4,645,714 $ 4,015,307 Operating income (loss): HPA $ 198,820 $ 210,441 $ 256,529 CSG (72,080) 107,814 66,576 ACG 627,708 1,233,388 968,573 All other (571,280) (325,574) (385,051) Operating income 183,168 1,226,069 906,627 Interest expense (68,463) (63,326) (75,198) Other income (expense), net 9,924 18,341 (24,049) Income before income taxes $ 124,629 $ 1,181,084 $ 807,380 . Fiscal Year 2023 2022 2021 Reconciliation of "All other" category: Stock-based compensation expense $ (105,580) $ (83,507) $ (89,322) Amortization of intangible assets (132,126) (150,128) (252,137) Restructuring related charges (114,094) (2,121) (2,722) Acquisition and integration related costs (23,311) (27,964) (32,946) Charges associated with a long-term capacity reservation agreement (1) (181,000) — — Goodwill impairment (12,411) (48,000) — Other (2) (2,758) (13,854) (7,924) Loss from operations for "All other" $ (571,280) $ (325,574) $ (385,051) (1) Refer to Note 11 for additional information. (2) Other includes fixed asset impairments, (loss) gain on sale of fixed assets, start-up costs and other miscellaneous corporate overhead expenses.

The Company and Its Significa_3

The Company and Its Significant Accounting Policies (Details) - USD ($) $ in Thousands			12 Months Ended
	Aug. 09, 2022	Jul. 02, 2022	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
The Company and Its Significant Accounting Policies [Line Items]
Revenue for product and services over time as a percent of total revenue			4%
Revenue, Remaining Performance Obligation, Amount			$ 167,800
Rebates As Percentage Of Sales [Less Than]			7%
Total remaining unearned compensation cost related to nonvested restricted stock units and options			$ 0
Goodwill, Impairment Loss		$ 0	12,411	$ 48,000	$ 0
Other Liabilities, Current			122,599	107,026
Increase (Decrease) in Income Taxes Payable			(33,240)	(3,139)	$ 34,618
Taxes Payable, Current			63,600	87,800
Employee-related Liabilities, Current			92,900	113,600
Accrued Rebate			42,800	$ 33,100
Business Combination, Contingent Consideration, Liability			$ 31,300
Investment tax credit, Percent	25%
Minimum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life			1 year
Maximum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life			39 years
Restricted Stock
The Company and Its Significant Accounting Policies [Line Items]
Total remaining unearned compensation cost related to nonvested restricted stock units and options			$ 137,600
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units and options			1 year 3 months 18 days

Concentrations of Credit Risk (

Concentrations of Credit Risk (Details)	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Revenue from significant customers
Three largest accounts receivable balances percentage [Line Items]	54%	57%
Sales Revenue, Net | Customer Concentration Risk | Apple
Revenue from significant customers
Percentage	12%	11%	7%
Percentage	12%	11%	7%
Sales Revenue, Net | Customer Concentration Risk | Apple
Revenue from significant customers
Percentage	37%	33%	30%
Percentage	37%	33%	30%

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Apr. 02, 2022
Components of inventories
Raw materials	$ 264,367	$ 236,095
Work in process	345,545	357,332
Finished goods	186,684	162,321
Total inventories	$ 796,596	$ 755,748

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Apr. 02, 2022
Property, Plant and Equipment [Abstract]
Land	$ 25,842	$ 25,842
Building and leasehold improvements	463,888	432,305
Machinery and equipment	2,430,307	2,401,735
Construction in progress	130,086	128,317
Property, Plant and Equipment, Gross	3,050,123	2,988,199
Less accumulated depreciation	(1,900,317)	(1,734,608)
Property and equipment, net	$ 1,149,806	$ 1,253,591

Business Acquisitions (Details

Business Acquisitions (Details Textual) - USD ($) $ in Thousands				12 Months Ended
	Oct. 19, 2021	Apr. 05, 2021	Oct. 01, 2020	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Business Acquisition [Line Items]
Goodwill, Acquired During Period				$ 2,760,813	$ 2,775,634
Business Combination, Contingent Consideration, Liability				$ 31,300
BUSINESS ACQUISITIONS				BUSINESS ACQUISITIONSDuring fiscal 2022, the Company completed the acquisitions of United SiC and NextInput, Inc. ("NextInput"). During fiscal 2021, the Company completed the acquisition of 7Hugs Labs S.A.S. ("7Hugs"). The goodwill resulting from these acquisitions is attributed to synergies and other benefits that are generated from these transactions. The operating results of these companies, which were not material either individually or in the aggregate, have been included in the Company's consolidated financial statements as of the acquisition dates. As a result, pro forma results of operations for these acquisitions have not been presented. United Silicon Carbide, Inc. On October 19, 2021, the Company acquired all the outstanding equity interests of United SiC, a leading manufacturer of silicon carbide ("SiC") power semiconductors, for a total purchase price of $236.7 million. The acquisition expanded the Company's offerings to include SiC power products for a range of applications such as electric vehicles, battery charging, IT infrastructure, renewables and circuit protection. The purchase price comprised cash consideration of $227.2 million and contingent consideration of up to $31.3 million which is to be paid to the sellers during the first quarter of fiscal 2024 (in accordance with the terms of the acquisition agreement) due to the achievement of certain revenue and gross margin targets over the period beginning on the acquisition date through December 31, 2022. The estimated fair value of the contingent consideration liability was $9.5 million as of the acquisition date. At April 2, 2022, the contingent consideration liability was remeasured to a fair value of $17.6 million and is included in "Other long-term liabilities" in the Consolidated Balance Sheet. The maximum contingent consideration of $31.3 million has been earned and is included in "Other current liabilities" in the Consolidated Balance Sheet as of April 1, 2023, with the increase in fair value recognized in "Other operating expense" in the Consolidated Statement of Income. Refer to Note 7 for further information related to the fair value measurement. During fiscal years 2023 and 2022, the Company recorded acquisition and integration related costs associated with the acquisition of United SiC totaling $14.6 million and $12.2 million, respectively, in "Other operating expense" in the Consolidated Statements of Income. During fiscal 2022, the Company also recorded $3.6 million of acquisition and integration related costs in "Cost of goods sold" in the Consolidated Statement of Income. NextInput, Inc. On April 5, 2021, the Company acquired all the outstanding equity interests of NextInput, a leader in microelectromechanical system ("MEMS")-based sensing solutions, for a total cash purchase price of $173.3 million. The acquisition expanded the Company's offerings of MEMS-based products for mobile applications, providing sensing solutions for a broad range of applications in other markets. During fiscal years 2023, 2022 and 2021, the Company recorded acquisition and integration related costs associated with the acquisition of NextInput totaling $2.1 million, $2.7 million and $1.8 million, respectively, in "Other operating expense" in the Consolidated Statements of Income. In connection with the Company's fiscal 2022 annual qualitative goodwill impairment assessment, it was determined that the market adoption of the acquired NextInput technology into mobile handsets was expected to be delayed compared to the previous assumptions. As a result, the Company completed a quantitative assessment of its reporting unit, which resulted in a goodwill impairment charge of $48.0 million. 7Hugs Labs S.A.S. In fiscal 2021, the Company acquired all the outstanding equity interests of 7Hugs, a private developer of ultra - wideband ("UWB") software and solutions, for a total cash purchase price of $48.7 million. During fiscal years 2023, 2022 and 2021, the Company recorded acquisition and integration related costs associated with the acquisition of 7Hugs totaling $0.1 million, $0.2 million and $2.4 million, respectively, in "Other operating expense" in the Consolidated Statements of Income.
In-process research and development
Business Acquisition [Line Items]
IPRD				$ 9,642	9,734
7Hugs
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 227,200
Business Combination, Consideration Transferred	236,700
Business Combination, Contingent Consideration, Liability	$ 9,500				17,600
7Hugs
Business Acquisition [Line Items]
Business Combination, Consideration Transferred			$ 48,700
NextInput
Business Acquisition [Line Items]
Business Combination, Consideration Transferred		$ 173,300
Maximum | 7Hugs
Business Acquisition [Line Items]
Business Combination, Contingent Consideration, Liability				31,300
Other Operating Income (Expense) [Member] | 7Hugs
Business Acquisition [Line Items]
Integration related costs				14,600	12,200
Other Operating Income (Expense) [Member] | 7Hugs
Business Acquisition [Line Items]
Integration related costs				100	200	$ 2,400
Other Operating Income (Expense) [Member] | NextInput
Business Acquisition [Line Items]
Integration related costs				2,100	2,700	1,800
Other Operating Income (Expense) [Member] | Other Acquisition
Business Acquisition [Line Items]
Integration related costs				$ 4,100	7,000	$ 23,100
Cost of Sales [Member] | 7Hugs
Business Acquisition [Line Items]
Integration related costs					$ 3,600

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details 1) - USD ($) $ in Thousands		12 Months Ended
	Jul. 02, 2022	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss	$ 0	$ 12,411	$ 48,000	$ 0
Gross carrying amounts and amortization of intangibles
Accumulated Amortization		451,235	470,990
Goodwill, Foreign Currency Translation Gain (Loss)		(2,685)
Gross Carrying Amount		988,938	1,145,776
Goodwill, Acquired During Period		2,760,813	2,775,634
fiscal year 2023
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss		12,400
All other
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss		12,411	48,000	$ 0
Technology licenses
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount		1,664	2,641
Accumulated Amortization		513	2,169
Customer Relationships
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount		104,616	104,778
Accumulated Amortization		67,485	47,208
Developed Technology
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount		872,106	1,026,690
Accumulated Amortization		382,448	420,255
Trade Names
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount		910	1,933
Accumulated Amortization		789	1,358
NextInput
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		572
United Silicon Carbide
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments		(297)
HPA
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss		0
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)		0
Goodwill, Acquired During Period		501,602	501,899
HPA | NextInput
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		0
HPA | United Silicon Carbide
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments		(297)
CSG
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss		12,411
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)		(2,685)
Goodwill, Acquired During Period		525,351	539,875
CSG | 7Hugs
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		0
CSG | NextInput
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		572
ACG
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss		0
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)		0
Goodwill, Acquired During Period		1,733,860	$ 1,733,860
ACG | 7Hugs
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		0
ACG | NextInput
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		$ 0

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details 2) $ in Thousands	Apr. 01, 2023 USD ($)
Estimated Amortization Expense
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 121,000
Finite-Lived Intangible Asset, Expected Amortization, Year Two	105,000
Finite-Lived Intangible Asset, Expected Amortization, Year Three	95,000
Finite-Lived Intangible Asset, Expected Amortization, Year Four	82,000
Finite-Lived Intangible Asset, Expected Amortization, Year Five	$ 54,000

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Details 3) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization	$ 132,425	$ 150,466	$ 252,898
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	$ 9,642	$ 9,734

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 2,760,813	$ 2,775,634
Accumulated impairment losses and write-offs	682,000	669,600
Amortization of Intangible Assets	132,425	150,466	$ 252,898
Finite-Lived Intangible Assets, Accumulated Amortization	451,235	470,990
Developed Technology
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	382,448	420,255
Customer Relationships
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 67,485	$ 47,208

Investments and Fair Value Me_3

Investments and Fair Value Measurements (Details) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Proceeds from Limited Partnership Investments	$ 2,500	$ 14,800	$ 5,900
Business Combination, Contingent Consideration, Liability	31,300
Equity Method Investments	20,400	27,100
Gain (Loss) on Investments	4,200	12,000	$ 21,500
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	40,653	39,356
Business Combination, Contingent Consideration, Liability	31,250	17,600
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	40,653	39,356
Business Combination, Contingent Consideration, Liability	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0	0
Business Combination, Contingent Consideration, Liability	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0	0
Business Combination, Contingent Consideration, Liability	31,250	17,600
Equity Securities | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	1,094	2,906
Equity Securities | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	1,094	2,906
Equity Securities | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	0	0
Equity Securities | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	$ 0	$ 0

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Lessee, Lease, Description [Line Items]
Operating lease expense	$ 20,162	$ 19,178	$ 17,382
Short-term lease expense	7,798	7,726	7,062
Variable lease expense	5,386	4,886	3,972
Operating Lease, Payments	21,480	20,536	18,697
Operating lease assets obtained in exchange for new lease liabilities	$ 28,940	$ 29,210	$ 12,899
Weighted-average remaining lease term (years) - operating leases	6 years 6 months	6 years 10 months 24 days
Weighted-average discount rate - operating leases	3.98%	2.99%
Less imputed interest	$ (11,080)
2022	22,037
2023	17,516
2024	15,270
2025	12,350
2026	11,270
Thereafter	21,150
Total lease payments	99,593
Present value of lease liabilities	88,513
Other Current Liabilities
Lessee, Lease, Description [Line Items]
Current operating lease liability	19,357	$ 17,393
Other Noncurrent Assets [Member]
Lessee, Lease, Description [Line Items]
Operating lease asset	83,490	73,683
Other Noncurrent Liabilities
Lessee, Lease, Description [Line Items]
Non-current operating lease liability	$ 69,156	$ 61,511

Debt (Details)

Debt (Details)								12 Months Ended
	Apr. 06, 2022	Dec. 14, 2021 USD ($) Rate	Dec. 01, 2020 USD ($)	Oct. 16, 2020 USD ($)	Sep. 29, 2020 USD ($)	Jun. 11, 2020 USD ($)	Jul. 16, 2018	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)	Apr. 03, 2021 USD ($)	Dec. 20, 2019 USD ($)	Sep. 30, 2019 USD ($)	Nov. 19, 2015
Debt Instrument [Line Items]
Total long-term debt								$ 2,048,073,000	$ 2,047,098,000
Gain (Loss) on Extinguishment of Debt								0	(744,000)	$ (61,991,000)
Interest Expense, Borrowings								72,300,000	67,000,000	79,300,000
Long-term Debt, Current Maturities								310,000	791,000
Net carrying amount of debt								2,048,073,000	2,047,098,000
Proceeds from borrowings and debt issuances (Note 9)								0	499,070,000	1,206,750,000
Line of Credit Facility, Remaining Borrowing Capacity					$ 500,000,000
Unamortized premium and issuance costs, net								3,283,000	4,692,000
Debt, Interest Rate, Default Increase, Percentage | Rate		0.25%
Defined Benefit Pension Plan, Net Periodic Benefit Cost								500,000	600,000	600,000
Maximum
Debt Instrument [Line Items]
Debt, Interest Rate, Default Increase, Percentage | Rate		1%
7.00% Senior Notes due 2025
Debt Instrument [Line Items]
Interest Paid, Including Capitalized Interest, Operating and Investing Activities										1,600,000
Debt Instrument, Interest Rate, Stated Percentage													7%
Debt Instrument, Redemption Price, Percentage			103.50%
Repayments of Senior Debt			$ 23,400,000
Interest paid										1,600,000
5.5% Senior Notes due 2026
Debt Instrument [Line Items]
Total long-term debt				$ 900,000,000
Gain (Loss) on Extinguishment of Debt										61,000,000
Redemption Premium										57,300,000
Write off of deferred issuance costs and bond premium										3,700,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities										37,300,000
Debt Instrument, Interest Rate, Stated Percentage							5.50%
Debt Instrument, Redemption Price, Percentage				106.363%
Interest paid										37,300,000
Net carrying amount of debt				$ 900,000,000
Senior Notes Due 2029 4.375% [Member]
Debt Instrument [Line Items]
Total long-term debt								850,000,000	850,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities								37,200,000	37,200,000	31,600,000
Debt Instrument, Face Amount						$ 300,000,000					$ 200,000,000	$ 350,000,000
Debt Instrument, Interest Rate, Stated Percentage												4.375%
Long-term Debt, Fair Value								785,900,000	852,600,000
Debt Instrument, Redemption Price, Percentage						104.375%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed							35%
Interest paid								37,200,000	37,200,000	31,600,000
Net carrying amount of debt								850,000,000	850,000,000
Debt Instrument, Redemption Price, Percentage, Excluding Make-Whole Premium						1
Credit Agreement [Member] | Federal Funds Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement [Member] | Base Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1%
Credit Agreement [Member] | Maximum | Base Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.25%
Credit Agreement [Member] | Maximum | Loan Lending Commitment Arrangement Fees
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.20%
Credit Agreement [Member] | Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.25%
Credit Agreement [Member] | Minimum | Base Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0%
Credit Agreement [Member] | Minimum | Loan Lending Commitment Arrangement Fees
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.15%
Credit Agreement [Member] | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1%
Finance leases [Member]
Debt Instrument [Line Items]
Total long-term debt								1,666,000	2,581,000
Net carrying amount of debt								1,666,000	2,581,000
3.375% Senior Notes due 2031
Debt Instrument [Line Items]
Total long-term debt								700,000,000	700,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities								23,600,000	23,600,000	11,900,000
Debt Instrument, Face Amount					$ 700,000,000
Debt Instrument, Interest Rate, Stated Percentage					3.375%
Long-term Debt, Fair Value								565,300,000	638,600,000
Debt Instrument, Redemption Price, Percentage					103.375%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed					40%
Interest paid								23,600,000	23,600,000	11,900,000
Net carrying amount of debt								700,000,000	700,000,000
Debt Instrument, Redemption Price, Percentage, Excluding Make-Whole Premium					1
Senior Notes Due 2024 1.750%
Debt Instrument [Line Items]
Total long-term debt								500,000,000	500,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities								8,800,000
Debt Instrument, Face Amount		$ 500,000,000
Debt Instrument, Interest Rate, Stated Percentage		1.75%
Long-term Debt, Fair Value								464,200,000	476,900,000
Interest paid								8,800,000
Net carrying amount of debt								500,000,000	500,000,000
Senior Notes
Debt Instrument [Line Items]
Interest Costs Capitalized								3,900,000	$ 3,700,000	$ 4,100,000
Revolving Credit Facility
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					$ 300,000,000
Proceeds from Lines of Credit								$ 0

Retirement Benefit Plans (Detai

Retirement Benefit Plans (Details) $ in Millions	12 Months Ended
	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)	Apr. 03, 2021 USD ($)
Retirement Benefit Plan (Textual)
Defined Contribution Plan, Company Contribution Amount	$ 18.8	$ 17.6	$ 15.6
Defined Benefit Pension Plan, Net Periodic Benefit Cost	0.5	0.6	$ 0.6
Assets held in rabbi trust	40.7	39.4
Assets held in rabbi trust, current	1.6	1.5
Assets held in rabbi trust, noncurrent	39.1	37.9
Foreign Plan [Member]
Retirement Benefit Plan (Textual)
Defined benefit plan insurance receivable	3.8
Defined Benefit Pension Plan, Benefit Obligation	$ 9.4	$ 12.1
Number of retirement benefit plans offered by the Company	2

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended	12 Months Ended
	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Dec. 31, 2022	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Commitments and Contingencies Disclosure [Abstract]
Purchase Obligation	$ 1,283,700					$ 1,283,700
Purchase Obligation, to be Paid, Year One	657,100					657,100
Purchase Obligation, to be Paid, Year Two	356,500					356,500
Purchase Obligation, to be Paid, Year Three	227,600					227,600
Purchase Obligation, to be Paid, Year Four	42,500					42,500
Maximum number of shares of common stock to be issued under plan	71,000	$ 8,000	$ 38,000	$ 13,000		227,101	$ 0	$ 5,281
Unrecorded Unconditional Purchase Obligation [Line Items]
Inventory Write-down		4,000	5,000	11,000
Inventory, Firm Purchase Commitment, Loss		12,000	43,000	86,000
Other Liabilities, Noncurrent	185,273					185,273	233,629
Other Liabilities, Current	122,599					122,599	107,026
Maximum number of shares of common stock to be issued under plan	71,000	$ 8,000	$ 38,000	13,000		227,101	0	5,281
Capitalized Contract Cost, Impairment Loss	71,000			110,000
Restructuring related charges						25,668	$ 2,100	$ 2,700
fiscal year 2023
Commitments and Contingencies Disclosure [Abstract]
Maximum number of shares of common stock to be issued under plan	74,800
Unrecorded Unconditional Purchase Obligation [Line Items]
Maximum number of shares of common stock to be issued under plan	$ 74,800
Restructuring related charges					$ 32,500	126,505
Cost of sales | fiscal year 2023
Unrecorded Unconditional Purchase Obligation [Line Items]
Restructuring related charges						$ 46,604
Loss on Long-Term Purchase Commitment
Unrecorded Unconditional Purchase Obligation [Line Items]
Other Liabilities, Noncurrent				78,000
Other Liabilities, Current				$ 8,000

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended	12 Months Ended
	Jul. 02, 2022	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Dec. 31, 2022	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							$ 25,668	$ 2,100	$ 2,700
Goodwill, Impairment Loss	$ 0						12,411	48,000	0
Restructuring Reserve		$ 5,248					5,248	0
Payments for Restructuring							(20,420)
Maximum number of shares of common stock to be issued under plan		71,000	$ 8,000	$ 38,000	$ 13,000		227,101	0	$ 5,281
fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges						$ 32,500	126,505
Goodwill, Impairment Loss							12,400
Maximum number of shares of common stock to be issued under plan		74,800
Other Restructuring Costs		6,800
Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							22,783
Restructuring Reserve		5,248					5,248
Payments for Restructuring							(17,535)
Contract Termination [Member] | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							22,783
impairment charges | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							88,426
Goodwill, Impairment Loss							12,411
One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							2,885
Restructuring Reserve		$ 0					0	$ 0
Payments for Restructuring							(2,885)
One-time termination benefits | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							2,885
Cost of sales | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							46,604
Cost of sales | Contract Termination [Member] | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							3,600
Cost of sales | impairment charges | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							43,004
Goodwill, Impairment Loss							0
Cost of sales | One-time termination benefits | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							0
Other operating expense | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							79,901
Other operating expense | Contract Termination [Member] | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							19,183
Other operating expense | impairment charges | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							45,422
Goodwill, Impairment Loss							12,411
Other operating expense | One-time termination benefits | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges							$ 2,885

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021	Mar. 28, 2020
Income (loss) before income taxes
United States	$ (466,070)	$ 69,938	$ 125,362
Foreign	590,699	1,111,146	682,018
Income before income taxes	124,629	1,181,084	807,380
Valuation Allowance [Line Items]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	1,900	1,000	6,200
Income (Loss) from Continuing Operations before Income Taxes, Domestic	(466,070)	69,938	125,362
Income (Loss) from Continuing Operations before Income Taxes, Foreign	590,699	1,111,146	682,018
Deferred Tax Liabilities, Gross	154,906	175,340
Deferred Tax Assets, in Process Research and Development	57,048	56,735
Deferred Tax Assets, Operating Loss Carryforwards	22,189	27,024
Unrecognized Tax Benefits, Expected to be Recognized Within the Next 12 Months	22,100
Lease liabilities	18,768	17,905
Deferred tax assets, Prepaids	17,360	0
Deferred tax assets, Deferred Revenue	14,475	0
Capitalized research and development expenses	13,794	6,040
Other non-current assets	38,060	36,824
Other long-term liabilities	14,647	84,628
Valuation Allowance	35,896	36,281	36,512	$ 35,280
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	(400)		1,200
Geographic Distribution, Domestic
Valuation Allowance [Line Items]
Valuation Allowance	35,570	34,987	33,647
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	583	1,339	2,144
Geographic Distribution, Foreign
Valuation Allowance [Line Items]
Valuation Allowance	326	1,294	2,865
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (968)	(1,570)	(912)
tax holiday
Valuation Allowance [Line Items]
Deferred Income Taxes and Tax Credits		$ 26,400
Cavendish [Member]
Valuation Allowance [Line Items]
Deferred Income Taxes and Tax Credits			$ 22,100

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Current (expense) benefit:
Federal	$ (21,704)	$ (16,886)	$ (11,043)
State	(488)	(274)	(140)
Foreign	(65,430)	(98,696)	(80,722)
Total current (expense) benefit	(87,622)	(115,856)	(91,905)
Deferred (expense) benefit:
Federal	60,351	(18,398)	(35,545)
State	2,371	(2,762)	(3,771)
Foreign	3,423	(10,715)	57,452
Total deferred (expense) benefit	66,145	(31,875)	18,136
Income tax expense (benefit)	$ 21,477	$ 147,731	$ 73,769

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
ReconciliationOfProvisionOfIncomeTaxes [Line Items]
Document Fiscal Year Focus	2023
Deferred Income Tax Expense (Benefit)	$ (66,145)	$ 31,875	$ (18,136)
Income tax expense at statutory federal rate	$ (26,172)	$ (248,028)	$ (169,550)
Income tax expense at statutory federal rate, Percentage	21%	21%	21%
Decrease (increase) resulting from:
State benefit (provision), net of federal (provision) benefit	$ 2,259	$ (1,888)	$ (743)
State benefit (provision), net of federal (provision) benefit, Percentage	(1.80%)	0.20%	0.10%
Effective Income Tax Rate Reconciliation, Tax Credit, Amount	$ 97,809	$ 118,877	$ 92,532
Effective Income Tax Rate Reconciliation, Tax Credit, Percent	(78.50%)	(10.10%)	(11.50%)
Effect of changes in income tax rate applied to net deferred tax assets	$ (950)	$ (25,679)	$ 22,286
Effect of changes in income tax rate applied to net deferred tax assets, Percentage	0.80%	2.20%	(2.80%)
Foreign tax rate difference	$ 73,491	$ 148,932	$ 85,851
Foreign tax rate difference, Percentage	(59.00%)	(12.60%)	(10.60%)
Foreign permanent differences, amount	$ (10,852)	$ 786	$ 9,026
Foreign permanent differences, percent	8.70%	(0.10%)	(1.10%)
Change in valuation allowance	$ 385	$ 231	$ (1,232)
Change in valuation allowance, Percentage	(0.30%)	(0.10%)	0.20%
Effective income tax rate reconciliation, expiration of state attributes, amount	$ (1,962)	$ (3,048)	$ (1,656)
Effective income tax rate reconciliation, expiration of state attributes, percent	1.60%	0.30%	0.20%
Stock-based compensation	$ (9,036)	$ 11,148	$ 9,545
Share-based compensation, Percentage	7.20%	(0.90%)	(1.20%)
Tax reserve adjustments	$ (9,437)	$ (3,262)	$ (9,979)
Tax reserve adjustments, Percentage	7.60%	0.30%	1.20%
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount	$ (128,708)	$ (130,874)	$ (100,830)
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent	103.30%	11.10%	12.50%
Effective income tax rate reconciliation, permanent reinvestment assertion, amount	$ (402)	$ (1,033)	$ (8,488)
Effective income tax rate reconciliation, permanent reinvestment assertion, percent	0.30%	0.10%	1.10%
Effective income tax rate reconciliation, Acquisition related adjustments, amount	$ (5,695)	$ (12,198)	$ (919)
Effective income tax rate reconciliation, Acquisition related adjustments, percent	4.50%	1%	0.10%
Other income tax benefit (expense)	$ (2,207)	$ (1,695)	$ 388
Other income tax benefit (expense), Percentage	1.80%	0.10%	(0.10%)
Income tax expense (benefit)	$ (21,477)	$ (147,731)	$ (73,769)
Total, Percentage	17.20%	12.50%	9.10%

Income Taxes (Details 3)

Income Taxes (Details 3) - USD ($) $ in Thousands	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021	Mar. 28, 2020
Deferred income tax assets:
Inventories	$ 24,374	$ 11,592
Net operating loss carryforwards	22,189	27,024
Research and other tax credits	57,048	56,735
Employee benefits	30,309	34,189
Lease liabilities	18,768	17,905
Other	15,898	10,332
Total deferred income tax assets	214,215	163,817
Valuation allowance	(35,896)	(36,281)	$ (36,512)	$ (35,280)
Total deferred income tax assets, net of valuation allowance	178,319	127,536
Deferred income tax liabilities:
Intangible assets	(69,050)	(79,452)
Property and equipment	(39,806)	(53,425)
Accrued tax on unremitted foreign earnings	(25,948)	(22,988)
Right-of-use assets	(17,457)	(16,591)
Other	2,645	2,884
Deferred Tax Assets, Net	23,413	(47,804)
Amounts included in consolidated balance sheets:
Other non-current assets	38,060	36,824
Other long-term liabilities	$ 14,647	$ 84,628

Income Taxes (Details 4)

Income Taxes (Details 4) - USD ($) $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Reconciliation of gross unrecognized tax benefits
Beginning balance	$ 144,055	$ 134,068	$ 119,222
Additions based on positions related to current year	9,718	11,826	10,048
Additions for tax positions in prior years	2,467	3,049	6,240
Reductions for tax positions in prior years	(363)	(1,669)	(348)
Expiration of statute of limitations	(3,546)	(3,219)	(1,094)
Settlements	0	0	0
Ending balance	$ 152,331	$ 144,055	$ 134,068

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021	Mar. 28, 2020
Income Taxes (Textual)
Valuation Allowance	$ 35,896	$ 36,281	$ 36,512	$ 35,280
Valuation Allowance, Deferred Tax Asset, Change in Amount	400		(1,200)
Foreign jurisdiction exemption reduction, Dollar Amount	65,500	128,400
Gross unrecognized tax benefits	152,331	144,055	134,068	$ 119,222
Unrecognized tax benefits, if recognized, would impact the effective tax rate	145,900	137,500	128,700
Interest and penalties expense (benefit) recognized related to uncertain tax positions	(900)	5,100	(800)
Accrued interest and penalties related to unrecognized tax benefits	1,900	1,000	6,200
Long-term Tax Liability	21,000
Taxes Payable, Current	63,600	87,800
Income tax expense (benefit)	21,477	147,731	73,769
Deferred Income Tax Expense (Benefit)	(66,145)	31,875	(18,136)
Tax settlement	0	0	0
Cavendish [Member]
Income Taxes (Textual)
Deferred Income Taxes and Tax Credits			$ 22,100
domestic net operating losses and credits
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount		$ (200)
U.S. Federal
Income Taxes (Textual)
Loss carryovers	32,100
State
Income Taxes (Textual)
Loss carryovers	107,900
Research Tax Credit Carryforward [Member]
Income Taxes (Textual)
Income tax credits	102,800
Foreign deferred tax assets
Income Taxes (Textual)
Loss carryovers	96,400
State
Income Taxes (Textual)
Income tax credits	$ 68,300
Basic
Income Taxes (Textual)
Foreign jurisdiction exemption reduction, per share amount	$ 0.64	$ 1.17
Diluted
Income Taxes (Textual)
Foreign jurisdiction exemption reduction, per share amount		$ 1.15

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Numerator:
Numerator for basic and diluted net (loss) income per share - net (loss) income available to common stockholders	$ 103,152	$ 1,033,353	$ 733,611
Denominator:
Denominator for basic net (loss) income per share — weighted average shares	102,206	110,196	114,034
Effect of dilutive securities:
Stock-based awards	813	1,350	1,982
Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions	103,019	111,546	116,016
Basic net (loss) income per share	$ 1.01	$ 9.38	$ 6.43
Diluted net (loss) income per share	$ 1	$ 9.26	$ 6.32
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	800

Net Income (Loss) Per Share (_2

Net Income (Loss) Per Share (Details Textual) shares in Millions	12 Months Ended
	Apr. 01, 2023 shares
Earnings Per Share [Abstract]
Shares excluded from the computation of diluted shares outstanding	0.8

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance at beginning balance, Shares	1,539
Balance at beginning balance, Weighted-Average Grant-Date Fair Value	$ 126.46
Granted, Shares	1,125
Granted, Weighted-Average Grant-Date Fair Value	$ 104.16
Vested, Shares	(703)
Vested, Weighted-Average Grant-Date Fair Value	$ 111.85
Forfeited, Shares	(129)
Forfeited, Weighted-Average Grant-Date Fair Value	$ 122.08
Balance at ending balance, Shares	1,832	1,539
Balance at ending balance, Weighted-Average Grant-Date Fair Value	$ 118.38	$ 126.46
Outstanding beginning balance, Shares	258
Outstanding beginning balance, Weighted-Average Exercise Price	$ 15.67
Granted, Shares	0
Granted, Weighted-Average Exercise Price	$ 0
Exercised, Shares	(187)
Exercised, Weighted-Average Exercise Price	$ 13.74
Canceled, Shares	(2)
Canceled, Weighted-Average Exercise Price	$ 14.19
Forfeited, Shares	0
Forfeited, Weighted-Average Exercise Price	$ 0
Outstanding ending balance, Shares	69	258
Outstanding ending balance, Weighted-Average Exercise Price	$ 20.95	$ 15.67
Outstanding ending balance, Weighted-Average Remaining Contractual Term	4 months 6 days
Outstanding ending balance, Aggregate Intrinsic Value	$ 5,562
Vested and expected to vest, Shares	69
Vested and expected to vest, Weighted-Average Exercise Price	$ 20.95
Vested and expected to vest, Weighted-Average Remaining Contractual Term	4 months 6 days
Vested and expected to vest, Aggregate Intrinsic Value	$ 5,562
Options exercisable, Shares	69
Options exercisable, Weighted-Average Exercise Price Ending Balance	$ 20.95
Options exercisable, Weighted-Average Remaining Contractual Term Ending Balance	4 months 6 days
Options exercisable, Aggregate Intrinsic Value	$ 5,562
Number of shares available for grant or issuance	4,398
Shares granted	0
Stock-based compensation expense	$ 105,580	$ 83,507	$ 89,322
Closing stock price				$ 101.57
Total intrinsic value of options exercised	16,500	27,100	66,700
Cash received from the exercise of stock options (excluding accrued unremitted employee funds)	$ 32,700
Annual forfeiture rate	1.40%
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 0
Total fair value of vested restricted stock units	74,100	$ 163,600	$ 121,800
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 137,600
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units	1 year 3 months 18 days
Vesting period	4 years
Performance and service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	2 years
Certain officers of the Company (Section 16 Officers)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	300
Shares granted	300
Stock-based compensation expense	$ 28,500
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	2,600
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	85%
Shares issued under plan	300	300	400
Share-Based Compensation Arrangement by Share-Based Payment Award, Cash Contribution	$ 0
2009 and 2012 Incentive Plans - TriQuint
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
2013 Incentive Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
2015 Inducement Stock Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
2012 Stock Incentive Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
2012 Stock Incentive Plan - Qorvo | Performance-based restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	200
Shares granted	200
2022 Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	4,400
Maximum number of shares of common stock to be issued under plan	4,500

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) shares in Thousands, $ in Millions	Apr. 01, 2023	Nov. 02, 2022	Apr. 02, 2022
Common stock reserved for future issuance
Outstanding stock options under formal directors’ and employees’ stock option plans	69		258
Possible future issuance under Company stock incentive plans	4,398
Employee stock purchase plan	2,639
Restricted stock-based units granted	1,832		1,539
Total shares reserved	8,938
Nov. 2022 Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Repurchase Program, Authorized Amount		$ 2,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 1,705

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Shareholders' Equity (Textual)
Stock Repurchased During Period, Shares	(8,664)	(7,306)	(3,642)
Document Fiscal Year Focus	2023
Stock Repurchased During Period, Value	$ 862,200	$ 1,152,287	$ 515,084
Document Period End Date	Apr. 01, 2023
Common stock reserved for future issuance	8,938
Common stock, shares authorized	405,000	405,000
Common Stock [Member]
Shareholders' Equity (Textual)
Stock Repurchased During Period, Value	$ 331,406	$ 276,035	$ 136,568

Operating Segment and Geograp_4

Operating Segment and Geographical Information (Details) - USD ($) $ in Thousands		3 Months Ended		12 Months Ended
	Jul. 02, 2022	Apr. 01, 2023	Jul. 02, 2022	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Segment Reporting Information [Line Items]
Goodwill, Impairment Loss	$ 0			$ 12,411	$ 48,000	$ 0
Revenues				3,569,399	4,645,714	4,015,307
Operating income				183,168	1,226,069	906,627
Interest expense				(68,463)	(63,326)	(75,198)
Other income (expense), net				9,924	18,341	(24,049)
(Loss) income before income taxes				124,629	1,181,084	807,380
Long-lived tangible assets		$ 1,149,806		1,149,806	1,253,591
Share-based Payment Arrangement, Noncash Expense				(105,580)	(83,507)	(89,322)
Amortization of Intangible Assets				(132,425)	(150,466)	(252,898)
Capitalized Contract Cost, Impairment Loss		71,000	$ 110,000
Restructuring related charges				25,668	2,100	2,700
United States
Segment Reporting Information [Line Items]
Revenues				1,817,960	1,928,403	1,631,110
CHINA
Segment Reporting Information [Line Items]
Revenues				741,405	1,499,212	1,579,017
Other Asia
Segment Reporting Information [Line Items]
Revenues				498,966	620,620	363,523
TAIWAN, PROVINCE OF CHINA
Segment Reporting Information [Line Items]
Revenues				308,642	345,869	248,708
Europe
Segment Reporting Information [Line Items]
Revenues				202,426	251,610	192,949
Geographic Concentration Risk [Member] | Property, Plant and Equipment | United States
Segment Reporting Information [Line Items]
Long-lived tangible assets		928,428		928,428	1,007,463
Geographic Concentration Risk [Member] | Property, Plant and Equipment | CHINA
Segment Reporting Information [Line Items]
Long-lived tangible assets		169,215		169,215	192,416
Geographic Concentration Risk [Member] | Property, Plant and Equipment | Other Countries
Segment Reporting Information [Line Items]
Long-lived tangible assets		$ 51,145		51,145	53,712
All other
Segment Reporting Information [Line Items]
Goodwill, Impairment Loss				12,411	48,000	0
Operating income				(571,280)	(325,574)	(385,051)
Share-based Payment Arrangement, Noncash Expense				(105,580)	(83,507)	(89,322)
Amortization of Intangible Assets				(132,126)	(150,128)	(252,137)
Business Combination, Acquisition And Integration related costs				(23,311)	(27,964)	(32,946)
Capitalized Contract Cost, Impairment Loss				181,000	0	0
Restructuring related charges				114,094	2,121	2,722
Other Unallocated Income Expense				(2,758)	(13,854)	(7,924)
HPA
Segment Reporting Information [Line Items]
Goodwill, Impairment Loss				0
HPA | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues				727,187	707,395	803,320
Operating income				198,820	210,441	256,529
CSG
Segment Reporting Information [Line Items]
Goodwill, Impairment Loss				12,411
CSG | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues				474,364	703,881	653,445
Operating income				(72,080)	107,814	66,576
ACG
Segment Reporting Information [Line Items]
Goodwill, Impairment Loss				0
ACG | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues				2,367,848	3,234,438	2,558,542
Operating income				$ 627,708	$ 1,233,388	$ 968,573